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Abstract 
 
 
 
H-Prune protein stimulates cellular motility and metastasis process of  breast 
cancer cells. The role of h-Prune in increased cell motility can be explained in 
part to h-Prune interaction with GSK-3β with which cooperatively works to 
regulate the disassembly of focal adhesions and promote cell migration. In the 
present study we use a transgenic mouse model to investigate the role of h-
Prune in the epidermis. We uncover defects in stratification, differentiation and 
barrier formation which can be attributed to a failure in basal keratinocytes 
proliferation and migration of ML-h-Prune transgenic mice. We highlight a 
role of h-Prune in substaining Wnt/β-catenin pathway thus investigating the 
molecular mechanism underlying the observed phenotype. We notice that h-
Prune overexpression lead to higher rate of GSK3-β phosphorylation resulting 
in its inactivation. To follow the Wnt pathway variation mediated by Prune in 
vivo, we generate a double transgenic mice model pVegfr2-luc/ML-h-Prune 
that shows an higher signal of bioluminescence driven by the pVegfr2 
promoter, in agreement of the maximum peak of h-Prune expression. Thus 
these analyses in vivo show that h-Prune is able to enhance VEGF-α, through 
its substaining activation of the WNT signaling in the mouse skin. Because of 
the knowledge of Notch signaling involved into an altered differentiation 
pattern of keratynocytes, we observed in the ML-h-Prune transgenic skin an 
unbalanced differentiation phenotype, thus we decide to analyze the level of 
the Notch pathway activation in transgenic mice skin. We show here a 
substantial  reduction of downstream effectors of these signaling in the h-Prune 
transgenic animals . The phenotype of our transgenic model is very close to an 
inflammatory phenotype, with  unbalancing levels of both WNT and Notch 
pathways, thus postulating a correlation of h-Prune overespression and 
consequent inflammation into the mice skin. For these reasons we analyzed h-
Prune together with β-catenin nuclearization in serial  sections of human 
psoriatic skin, asserting an involvement of h-Prune in these pathology, a 
disease which retains both  proinflammatory insult and higher WNT-activated 
proliferation phenotype. This model could be the base for future studies that 
will assess properties and functions of h-Prune in human disorders which are 
related to hyperproliferation and inflammation of the skin. This is an attempt to 
find  molecular targets for future therapeutic applications in the treatment of 
inflammatory skin pathologies. 
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1.1.H-Prune 
 
H-Prune is the human homologue of the Drosophila 
Prune gene was originally characterized based on Drosophila mutant 
phenotypes. Prune (or DRES17) was identified as a gene that is involved in eye 
development in a Drosophila model, starting from a subset of human ESTs 
homologous to Drosophila mutant genes called Drosophila-related expressed 
sequences (DRES) [Banfi, et al. 1996]. The Drosophila Prune mutant showed a 
brownish-purple eye colour due to a reduction in drosopteridines, in contrast to 
the bright red eye of the wild type fly [Timmons and Shearn 1996]. The 
metabolic defects in the Prune fly do not affect viability and fertility; however, 
the homozygous or hemizygous Prune mutation is lethal in the presence of a 
single copy mutation of the abnormal wing disc gene (awd; also known as 
killer-of-Prune).  
The product of h-Prune gene is a protein that belongs to 
the DHH protein superfamily, which includes several phosphodiesterases 
(PDEs), such as RecJ, a bacterial nuclease, and different yeast and bacteria 
pyrophosphatases [Aravind and Koonin 1998]. The DHH superfamily can be 
divided into two main groups on the basis of a C-terminal motif that is very 
well conserved within each group, but not across the groups. All the members 
of this superfamily possess four other motifs that contain highly conserved 
charged residues which are predicted to be responsible for ion binding and for 
catalysing the PDE reaction. The most characteristic motif is the third, with the 
signature DHH (Asp-His-His), after which this superfamily was named. At N-
terminus of the h-Prune sequence (residues 10–180) is located the DHH 
domain, along with an adjacent, less conserved, DHHA2 domain  [D'Angelo, 
et al. 2004] that provides substrate-binding residues and therefore influences 
specificity. The DHHA2 domain is therefore important in studies of possible 
substrates of h-Prune. This domain is followed by a C-terminal cortexillin-
homology region with putative coiled-coil and proline-rich regions.  
 
 
 
Fig 1.  Drosophila Prune mutant and Molecular domains of h-Prune. 
A.Drosophila Prune mutant showed a brownish-purple eye colour due to a reduction in 
drosopteridines, in contrast to the bright red eye of the wildtype fly [Timmons and 
Shearn 1996]. B.  The N-terminus of the h-Prune sequence contains the DHH (residues 
10–180) and DHHA2 (residues 215–350) domains involved in its enzymatic function. 
These domains are followed by a cortexillin-homology domain (CHD, 370–453 
residues) containing putative coiled-coil and proline-rich regions. The C-terminal region 
of h-Prune is responsible for the h-Prune interaction with GSK-3β (330–453 residues).  
Prune mutant 
Prune WT 
A B 
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The human PRUNE gene is ubiquitously expressed in 
adult tissues, while its expression during mouse development is particulary 
high in the central nervous system (CNS), specifically in the cranial and dorsal 
root ganglia [Reymond, et al. 1999] H-PRUNE is located in the 1q21.3 
chromosomal region, 1Mb upstream the epidermal differentiation complex 
(EDC), a region which shows a remarkable density of genes that fulfil 
important functions in terminal differentiation of the human epidermis 
[Mischke, et al. 1996]. Linkage studies have shown in this region two 
susceptibility loci for skin inflammation disorders such as psoriasis [Capon, et 
al. 1999, Hardas, et al. 1996] and atopic dermatitis [Cookson, et al. 2001] for 
which  no genes have been yet identified.  
H-Prune participates in a complex network of 
interactions with proteins involved in cell cycle and cell motility. In vitro 
experiments have shown that h-Prune overexpression increases cellular 
proliferation in NIH3T3 cells [Forus, et al. 2001]. It has recently been shown 
that together with GSK-3β, h-Prune cooperatively regulates the disassembly of 
focal adhesions, to promote cell migration. In-vitro binding studies using these 
recombinant proteins have demonstrated that GSK-3β binds directly to h-
Prune. The aminoacid region spanning from residue 333 to residue 453 of h-
Prune is necessary and sufficient for the complex formation with GSK-3β in 
intact cells. GSK-3β kinase inactive mutants or GSK3β inhibitor treatment 
decreases the formation of the complex between GSK3β and h-Prune and 
suppresses cell migration. These results indicate that the kinase activity of 
GSK-3β is required for its interaction with h-Prune in intact cells [Kobayashi, 
et al. 2006]. 
 
 
 
1.2. The skin 
 
 
1.2.1. Skin anatomy 
 
Skin is the largest organ in the body. Human skin 
consists of a stratified, cellular epidermis and an underlying dermis of 
connective tissue. Beneath the dermis is a layer of subcutaneous fat, which is 
separated from the rest of the body by a vestigial layer of striated muscle. The 
epidermis is mainly composed of keratinocytes and is typically 0.05–0.1 mm in 
thickness. It is formed by division of cells in the basal layer which give rise to 
the spinous layer. This layer contains cells that move outwards and 
progressively differentiate, forming the granular layer and the stratum 
corneum. The cellular progression from the basal layer to the skin surface takes 
about 30 days but is accelerated in diseases such as psoriasis. The ‘bricklike’ 
shape of keratinocytes is provided by a cytoskeleton made of keratin 
intermediate filaments. As the epidermis differentiates, the keratinocytes 
become flattened. This process involves the filament aggregating protein, 
filaggrin, a protein component of keratohyalin granules. Indeed, keratin and 
filaggrin comprise 80–90% of the mass of the epidermis. The outermost layer 
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of the epidermis is the stratum corneum, where cells (now called corneocytes) 
have lost nuclei and cytoplasmic organelles. The corneocyte has a highly 
insoluble, cornified envelope within the plasma membrane, formed by cross-
linking of soluble protein precursors, including involucrin and loricrin, the 
latter contributing 70–85% to the mass of the cornified cell envelope; it also 
contains several lipids (fatty acids, sterols and ceramides) released from 
lamellar bodies within the upper  living epidermis.  
Other cells in the epidermis are the melanocytes, 
Langerhans’ cells and Merkel cells. Melanocytes are dendritic cells that 
distribute packages of melanin pigment in melanosomes to surrounding 
keratinocytes to give skin its colour. The number of melanocytes does not 
differ much between white and black skin. Rather it is the nature of the 
melanin and the size of the melanosomes that account for the different 
appearances [Lin and Fisher 2007]. The Langerhans’ cells are also dendritic in 
nature, although these are of mesenchymal origin and originate from bone 
marrow. Langerhans’ cells are antigen-presenting cells and process antigens 
encountered by the skin to local lymph nodes and thus have a key role in 
adaptive immune responses in the skin. Merkel cells are probably derived from 
keratinocytes. They have a role as mechanosensory receptors in response to 
touch. Human skin contains pilosebaceous follicles and sweat glands. The hair 
follicles comprise pockets of epithelium that are continuous with the 
superficial epidermis but which also envelop a small papilla of dermis at their 
base. A bundle of smooth muscle, the arrector pili, extends at an angle between 
the surface of the dermis and a point in the follicle wall. Above the insertion, 
there are holocrine sebaceous glands which open into the pilary canal. In some 
sites, such as the axillae, the follicles may be associated with apocrine glands. 
Also derived from the epidermis and opening directly to the skin surface are 
the eccrine sweat glands.  
The epidermis is attached to the dermis via a complex 
network of proteins and glycoproteins that extend from inside basal 
keratinocytes into the superficial dermis. Besides adhesion, the dermal–
epidermal junction components also contribute to cell migration (for example 
during wound healing) as well as epithelial–mesenchymal signaling events. 
Over 30 different macromolecules (collagens, laminins, integrins) interact 
within a basement membrane zone that is less than 200 µm across. The dermis 
is a supporting matrix or ground substance in which polysaccharides and 
proteins are linked to produce macromolecules that have a remarkable capacity 
for retaining water. The thickness of the dermis varies from less than 0.5 mm 
to more than 5 mm. There are two principal types of protein fibre: collagen and 
elastic tissue. Collagen is the major extracellular matrix protein comprising 80–
85% of the dry weight of the dermis. Twenty-nine different collagens have 
been identified in vertebrate tissue (depicted by Roman numerals in the order 
of their discovery, from I to XXIX), of which at least 12 are expressed in skin. 
The main interstitial dermal collagens are types I and III whereas the principal 
basement membrane collagen (at the dermal–epidermal junction and around 
dermal blood vessels, nerves and appendages) is type IV collagen. Triple-
helical collagen monomers polymerize into fibrils and fibres, which then 
become stabilized by the complex formation of both intra- and intermolecular 
crosslinks. Collagen fibres are extremely tough and provide skin with its 
tensile strength. Elastic fibres account for no more than 2–4% of the 
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extracellular matrix in the dermis and consist of two components, elastin and 
elastin-associated microfibrils, which together give skin its elasticity and 
resilience. Elastic microfibrils are composed of several proteins, including 
fibrillin, which surround the elastin and which can extend throughout the 
dermis in a web-like configuration to the junction between the dermis and the 
epidermis. The dermis also contains a number of non-collagenous 
glycoproteins, including fibronectins, fibulins and integrins. These 
extracellular matrix components facilitate cell adhesion and cell motility. 
Between the dermal collagen and elastic tissue is the ground substance made 
up of glycosaminoglycan/proteoglycan macromolecules. These contribute only 
0.1–0.3% of the total dry weight of the dermis but provide a vital role by 
maintaining hydration, mostly due to the high water-binding capacity of 
hyaluronic acid. About 60% of the total weight of the dermis is water. The 
dermis has a very rich blood supply, although no vessels pass through the 
dermal–epidermal junction. There is a superficial and a deep vascular plexus. 
The motor innervation of the skin is autonomic, and includes a cholinergic 
component to the eccrine sweat glands and adrenergic components to both the 
eccrine and apocrine glands, to the smooth muscle and the arterioles and to the 
arrector pili muscle. The sensory nerve endings are of several kinds; some are 
free, some terminate in hair follicles and others have expanded tips [Mc Grath 
and Uitto 2010]. 
 
 Fig 2.  The skin and its  appendages.  The skin is made up epidermis, dermis 
and subcutaneous fat layer (subcutis). The epidermis is the thin outer layer of the skin. 
The dermis is the middle layer of the skin. The dermis contains blood vessels, lymph 
vessels, hair follicles, sweat glands, collagen bundles, fibroblasts, nerves. The dermis 
gives skin flexibility and strength. It also contains pain and touch receptors. The 
subcutis is the deepest layer of skin. It consisting of a network of collagen and fat cells, 
helps conserve the body's heat and protects the body from injury by acting as a shock 
absorber. (Modified from Mc Grath & Ulitto, Rook’s Textbook of Dermatology, 2010).    
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1.2.2.Function of Skin 
 
A key role of skin is to provide a mechanical barrier 
against the external environment. The cornified cell envelope and the stratum 
corneum restrict water loss from the skin while keratinocyte-derived 
endogenous antibiotics (defensins and cathelicidins) provide an innate immune 
defence against bacteria, viruses and fungi. The epidermis also contains a 
network of about 2 x109 Langerhans’ cells, which serve as sentinel cells whose 
prime function is to survey the epidermal environment and to initiate an 
immune response against microbial threats, although they may also contribute 
to immune tolerance in the skin. Melanin, which is mostly found in basal 
keratinocytes, also provides some protection against DNA damage from 
ultraviolet radiation. An important function of skin is thermoregulation. 
Vasodilatation or vasoconstriction of the blood vessels in the deep or 
superficial plexuses helps regulate heat loss. Eccrine sweat glands are found at 
all skin sites and are present in densities of 100–600/cm2; they play a role in 
heat control and produce approximately 1 litre of sweat per hour during 
moderate exercise. Secretions from apocrine sweat glands contribute to body 
odour (pheromones). Skin lubrication and waterproofing is provided by sebum 
secreted from sebaceous glands. Subcutaneous fat has important roles in 
cushioning trauma as well as providing insulation and a calorie reserve. In non-
obese subjects, about 80% of the body’s total fat is found in subcutaneous 
tissue. Fat also has an endocrine function, releasing the hormone leptin, which 
acts on the hypothalamus to regulate hunger and energy metabolism. Other 
functions of fat cells include tissue remodelling and phagocytosis. Skin also 
has a key function in synthesizing various metabolic products, such as vitamin 
D [Mc Grath and Uitto 2010]. 
 
1.2.3.Epidermal structures 
 
The normal epidermis is a terminally differentiated, 
stratified, squamous epithelium. The major cell, making up 95% of the total, is 
the keratinocyte, which moves progressively from attachment to the epidermal 
basement membrane towards the skin surface, forming several well-defined 
layers during its transit [Houben, et al. 2007]. Thus, on simple morphological 
grounds, the epidermis can be divided into four distinct layers: stratum basale 
or stratum germinativum, stratum spinosum, stratum granulosum and stratum 
corneum. The term Malpighian layer includes both the basal and spinous cells. 
Other cells within the epidermis include melanocytes, Langerhans’ cells and 
Merkel cells. The stratum basale is a continuous layer that is generally only 
one cell thick but it may be two to three cells thick in glabrous skin and in 
hyperproliferative epidermis. The basal cells are small and cuboidal (10–14 nm 
in diameter) and have large, dark staining nuclei, and dense cytoplasm which 
contains many ribosomes and dense tonofilament bundles. Immediately above 
the basal cell layer, the epibasal keratinocytes enlarge to form the 
spinous/prickle-cell layer or stratum spinosum. The stratum spinosum is 
succeeded by the stratum granulosum or granular layer, which contains 
intracellular granules of keratohyalin. At high magnification, the dense mass of 
keratohyalin granules from human epidermis has a particulate substructure, 
with particles of irregular shape, on average 2 nm in length, and occurring 
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randomly in rows or lattices. The cytoplasm of cells of the upper, spinous layer 
and granular cell layer also contains smaller lamellated granules averaging 
100–300 nm in size, which are known as lamellar granules or bodies, 
membrane-coating granules. These are numerous within the uppermost cells of 
the spinous layer and migrate towards the periphery of the cells as they enter 
the granular cell layer. They discharge their lipid components into the 
intercellular space, playing important roles in barrier function and intercellular 
cohesion within the stratum corneum [Feingold 2007]. The outermost layer of 
epidermis is the stratum corneum where cells (now corneocytes) have lost 
nuclei and cytoplasmic organelles. The cells become flattened and the keratin 
filaments align into disulphide cross-linked macrofibres, under the influence of 
filaggrin, the protein component of the keratohyalin granule, responsible for 
keratin filament aggregation. The key role of filaggrin in skin biology has been 
demonstrated by the discovery of very common loss-of-function mutations in 
the filaggrin gene as the cause of the genetic disorder ichthyosis vulgaris and as 
a major risk factor for the development of atopic dermatitis, atopic asthma and 
systemic allergies [Sandilands, et al. 2006]. The corneocyte has a highly 
insoluble, cornified envelope within the plasma membrane, formed by 
crosslinking of the soluble protein precursor, involucrin, following the action 
of a specific epidermal transglutaminase also synthesized in the high stratum 
spinosum. The process of desquamation involves degradation of the lamellated 
lipid in the intercellular spaces and loss of the residual intercellular 
desmosomal interconnections [Milstone 2004]. In palmoplantar skin there is an 
additional zone, also electron-lucent, the stratum lucidum, between the 
granulosum and corneum. These cells are still nucleated, and may be referred 
to as ‘transitional’ cells. 
 
 
Fig 3.  Structure of epidermis.  The epidermis contains 4 layers. From bottom to 
top the layers are named stratum basale, stratum spinosum, stratum granulosum and 
stratum corneum. The bottom layer, the stratum basale, has cells that are shaped like 
columns. In this layer the cells divide and push already formed cells into higher layers. 
As the cells move into the higher layers, they flatten and eventually die. The top layer 
of the epidermis, the stratum corneum, is made of dead, flat skin cells that shed about 
every 2 weeks. (Modified from Mc Grath & Ulitto, Rook’s Textbook of Dermatology, 
2010) 
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1.2.4.Keratinocytes  
 
The keratinocytes are named so, cause the intermediate 
filaments, that make up the cytoskeleton of this cells, are composed of keratin. 
The human genome possesses 54 functional keratin genes located in two 
compact gene clusters, as well as many nonfunctional pseudogenes, scattered 
around the genome  [Schweizer, et al. 2006]. Keratin genes are very specific in 
their expression patterns. Each one of the many highly specialized epithelial 
tissues has its own profile of keratin gene expression. Hair and nails express 
modified keratins, containing large amounts of the amino acid cysteine which 
forms numerous chemical cross-links to further strengthen the cytoskeleton. 
The genes encoding individual keratins fall into two gene 
families: type I (basic) and type II (acidic). Mapping the tissue distribution of 
keratins shows coexpression of particular acidic–basic pairs in a cell- and 
tissue-specific manner. Heterodimers are assembled into higher-order 
protofibrils and protofilaments by an antiparallel stagger of some complexity. 
Simple epithelia are characterized by the keratin pair K8/K18, and the stratified 
squamous epithelia by K5/K14. In addition, stratified squamous epithelia 
express up to four other keratin pairs during epithelial differentiation. In skin, 
suprabasal keratins K1/K10 are characteristic of epidermal differentiation. In 
the stratum granulosum, release of filaggrin from the keratohyalin granules 
forms macrofibers. Retinoid levels, growth factors and hormones may regulate 
keratin gene expression. Mesenchymal signals may also direct or permit 
intrinsic patterns of keratinocyte differentiation. K15 is expressed in basal 
keratinocytes of the hairfollicle bulge region at the site of pluripotential stem 
cells. K9 and K2e expression is site restricted in skin: K9 to palmoplantar 
epidermis and K2e to superficial interfollicular epidermis. Apart from their 
structural properties, keratins may also have direct roles in cell signaling, the 
stress response and apoptosis [Magin, et al. 2007]. In epidermal 
hyperproliferation, as in wound healing and psoriasis, expression of suprabasal 
keratins K6/K16/K17 is rapidly induced. Currently, 21 of the 54 known keratin 
genes have been linked to monogenic genetic disorders, and some have been 
implicated in more complex traits, such as idiopathic liver disease or 
inflammatory bowel disease [Uitto, et al. 2007]. 
 
 
 
 
1.2.5.Skin barrier 
 
One of the key functions of the epidermis is to form a 
barrier against the external environment. To that end, terminal differentiation 
of keratinocytes leads to formation of the cornified cell envelope. The cornified 
envelope is rendered highly insoluble by the formation of glutamyl-lysyl 
isodipeptide bonds between envelope proteins, catalysed by transglutaminases 
[Candi, et al. 2005]. Involucrin is the best-established envelope precursor 
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although it is also a marker of differentiation in epithelia such as cornea. Other 
cytosolic envelope precursors include the family of small proline-rich proteins 
(SPR1) including cornifin or SPR1 and pancornulins. Other envelope proteins 
include SKALP/elafin and keratolinin/cystatin, a 36-kDa protein cross-linked 
by transglutaminase into a 150-kDa multimer. Some precursors of the cornified 
envelope are delivered by granules. Small, smooth, sulphur-rich L granules 
contain the cysteine-rich protein loricrin, and accumulate in the stratum 
granulosum [Ishida-Yamamoto, et al. 1999].  
Loricrin is the major component of the cornified 
envelope. Expression of loricrin depends on a high calcium concentration and 
is down-regulated by retinoids. Loricrin gene expression is limited to 
terminally differentiating keratinocytes of stratified squamous epithelia. Due to 
the characteristic pattern expression of this protein, its promoter is often used 
to drive the expression of transgenes in the epidermis. In the 1999 was created 
a modified Loricrin promoter (ML) that was able to drive the transgene 
expression in all four layer of epidermis [DiSepio, et al. 1999]. The ML 
promoter was extensively used to obtain specific expression of transgene in the 
entire epidermis. In the 1999 Waikel and colleagues used this promoter 
upstream Human c-Myc cDNA, obtained an overexpression of the oncogene in 
the entire epidermis. However the expression described in the work was not 
lasting: ML-myc2 pups exhibit a severe hyperkeratotic phenotype, which 
develops on day 4. The phenotype persists for several more days and then the 
pups begin to normalize [Waikel, et al. 1999].  
    Profilaggrin in F granules may make a minor 
contribution to the envelope. Membrane-associated proteins that contribute to 
the cornified envelope include the plakin family members, periplakin, 
envoplakin, epiplakin, desmoplakin as well as plectin. Formation of the 
cornified cell envelope is triggered by a rise in intracellular calcium levels 
[Bikle, et al. 2004]. This leads to cross-link formation between plakins and 
involucrin catalysed by transglutaminase. Other desmosomal proteins are then 
also cross-linked, forming a scaffold along the entire inner surface of the 
plasma membrane. Ceramides from the secreted contents of lamellar bodies are 
then esterified onto glutamine residues of the scaffold proteins. The cornified 
cell envelope is reinforced by the addition of a variable amount of SPRs, 
repetin, trichohyalin, cystostatin α, elafin and LEP/XP-5 (skin-specific 
protein). Although most desmosomal components are degraded, keratin 
intermediate filaments (mostly K1, K10 and K2e) may be cross-linked to 
desmoplakin and envoplakin remnants. Together these assembly and 
degradation events result in durable, flexible but dead cells that have vital 
mechanical and water-permeability barrier functions.  
During epidermal differentiation, there are profound 
changes in the composition of lipids; in the viable layers phospholipids, 
cholesterol and triglycerides predominate, but in the upper stratum spinosum 
and stratum granulosum lipid is synthesized and packaged into lamellated, 
membrane-bound organelles known as membrane-coating granules, lamellar 
granules or Odland bodies [Elias, et al. 2008]. They are found adjacent to the 
cell membrane with alternating thick and thin dense lines separated by lighter 
lamellae of equal width, consistent with packing of flattened discs within a 
membrane boundary. Immunochemistry has confirmed the presence of 
phospholipids, glycolipids and free sterols. The organelles move towards the 
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plasma membrane as the cells move through the granular layer and cluster at 
the cell membrane. They fuse with the plasma membrane, dispersing their 
contents into the intercellular space. Polar lipids from the lamellar granules are 
remodelled into neutral lipids in the intercellular space between corneocytes, 
forming an important barrier to permeability. The lamellar granules also 
contain hydrolytic enzymes, lipases and glycosidases, which are responsible 
for this remodelling. Thus, the stratum corneum is rich in ceramides, free 
sterols and free fatty acids. Linoleate appears to be essential for proper barrier 
function as an ester-linked residue in acyl ceramides; thus, in essential fatty 
acid deficiency, substitution of this linoleate by oleate causes a defect in barrier 
function. The skin is an active lipid-synthesizing tissue, with a daily production 
rate of 100 mg/day. In human epidermis, nearly all sterol is present as 
cholesterol. In many cells, cholesterol biosynthesis may be modulated by 
uptake of exogenous cholesterol, mediated by low-density lipoprotein (LDL) 
receptors, but these are only present on the plasma membrane of basal 
keratinocytes, and are rapidly down-regulated on epidermal differentiation. 
Sterol synthesis is higher in the stratum granulosum, and is thus relatively 
autonomous and uninfluenced by dietary or circulating sterol levels. 
Cholesterol sulphate is highest in the stratum granulosum and corneum, where 
it is thought to play a role in cell cohesion.  
 
 
1.2.6.Skin maintenance 
 
Responsible of maintaining skin homeostasis, regenerate 
skin appendages and repair itself after injury, are the stem cells which reside in 
the bulge area of hair follicles, the basal layer of interfollicular epidermis and 
the base of sebaceous glands [Braun and Prowse 2006]. These stem cells 
generate a proliferative progeny that can undergo differentiation. Stem cells are 
able to self-renew as well as give rise to the differentiating cells [Fuchs 2008]. 
In the epidermis, some basal cells can periodically withdraw from the cell 
cycle and commit to terminal differentiation. It is still not clear, however, 
whether every cell or only a proportion of cells in the basal layer is a stem cell. 
One long-established theory divides basal keratinocytes into epidermal 
proliferation units, which comprise one self-renewing stem cell and about 10 
tightly packed, transient, amplifying cells (each capable of dividing several 
times and then exiting the basal layer to undergo terminal differentiation) 
[Potten 1974]. This unit gives rise to a column of larger and flatter cells that 
culminates in a single hexagonal surface. Stem cells within epidermal 
proliferation units are associated with a profile of particular chemical, 
molecular and biological characteristics [Watt and Hogan 2000]. For example, 
stem cells retain labelling with injected 3H-thymidine or Brdu after repeated 
cell division. In culture, actively growing clones present after serial passaging 
are considered to indicate an origin from stem cells. Potential markers of 
interfollicular epidermal stem cells are α6 and β1 integrin as well as p63, 
whereas sebocyte stem cells express Blimp1. Markers of hair follicle bulge 
stem cells include CD34, NFATc1, vitamin D receptor, TCF3, Sox9 and Lhx2. 
In the epidermal proliferation unit concept of stem cell behaviour, the division 
of basal cells has been viewed as a symmetrical process in which equal 
daughter cells are generated; the basal cells progressively reduce their 
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adhesiveness to the underlying epidermal basement membrane, delaminate and 
commit to terminal differentiation. However, recent data suggest that basal 
cells can also undergo asymmetrical cell division, shifting their spindle 
orientation from lateral to perpendicular [Lechler and Fuchs 2005]. 
Asymmetrical cell divisions provide a natural means of maintaining a 
proliferative daughter cell that retains the cell markers associated with stem 
cells, while the other daughter cell has reduced markers such as β1 integrin, 
increased expression of Notch signals, and is committed to terminal 
differentiation. Asymmetrical cell divisions, therefore, can bypass the need for 
transient amplifying cells. The structural and biological composition of the 
dermal–epidermal junction also influences the proliferative properties of basal 
keratinocytes. Laminin-332 promotes anchorage as a ligand via α6β4 integrins 
in hemidesmosomes and signaling/migration via its association with α3β1 in 
focal adhesions. Signaling via α3β1 integrin stimulates the MAP-kinase 
pathway, turnover of focal adhesions and epidermal migration. The basement 
membrane is also a reservoir for growth factors that can promote epidermal 
proliferation (e.g. TGF-α, EGFs and insulin growth factors) or restrict it (e.g. 
TGF-β). EGFR signaling also enhances proliferation and migration in the 
epidermis, possibly by phosphorylating β4 integrin and promoting 
hemidesmosome disassembly. Thus the control of basal keratinocyte stem cell 
activity in maintaining homeostasis and responding to injury is through the 
regulation of at least two opposing tyrosine kinase pathways and two integrin 
structures. 
A key transcription factor in regulating the self-renewal 
and long-term proliferative capacity of the stem cell is p63, a member of the 
p53 family of proto-oncogenes. However, the precise role of p63 is not clear; it 
may have a direct effect on stem-cell renewal, or lineage commitment, and/or 
an effect on switching from proliferation to terminal differentiation [Truong 
and Khavari 2007].  
Stem cells in hair follicles are located in the lowest 
permanent part of the follicle, within the outer root sheath. These cells cycle 
more slowly than other cells and have the capacity to migrate (e.g. to the base 
of the hair follicle in follicular regeneration), as well as to differentiate into 
diverse lineages (e.g. outer root sheath, inner root sheath, hair shaft, sebocytes 
and interfollicular epidermis). Despite this multipotency, however, the follicle 
stem cells only function in pilosebaceous unit homeostasis and do not 
contribute to interfollicular epidermis unless the skin is wounded [Ito, et al. 
2007]. Hair follicles undergo cycles of degeneration and regeneration 
throughout life. During the growth phase (anagen), which requires activation of 
hair follicle stem cells, matrix cells proliferate rapidly but then undergo sudden 
apoptosis (catagen). The hair bulb and root shrivel to form an epithelial strand 
which forces the dermal papilla to rest at the base of the non-cycling part of the 
hair follicle [Cotsarelis 2006]. The hairs then enter a resting phase (telogen). At 
a molecular level, inhibition of BMP signaling and activation of Wnt signaling 
converge to regulate stem cell activation. From microarray studies, Sox9, Tcf3 
and Lhx2 appear to be markers of follicular stem cells whether they are 
quiescent or proliferative.  
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1.3.Wnt signaling 
 
Wnts are a family of secreted, cysteine-rich, 
glycosylated, protein ligands that influence cell growth, differentiation, 
migration and fate [Miller 2002, Polakis 2000, Smalley and Dale 1999]. 
Members of  Wnt family have been identified in organisms ranging in 
complexity from the cnidarian Hydra to humans; at least 19 different Wnts 
exist in mammals [Miller 2002]. Severe developmental defects usually occur in 
mice that have defective Wnt signaling.  
One of the pathways regulated by Wnt molecules is 
termed “canonical Wnt pathway” or “Wnt/β-catenin pathway” [Huelsken and 
Behrens 2002, Polakis 2000, Seidensticker and Behrens 2000, Sharpe, et al. 
2001]. In the canonical Wnt pathway, Wnt signal transduction ultimately 
results in the activation of genes regulated by the T-cell factor (TCF)/lymphoid 
enhancer factor (LEF) family of architectural transcription factors [Barker, et 
al. 2000, Brantjes, et al. 2002, Novak and Dedhar 1999].  
The effector molecule responsible for activating 
TCF/LEF-responsive genes is β-catenin, which serves as a transactivator that 
binds to DNA bound TCF/LEFs. As in insulin signaling, GSK-3β plays a key 
inhibitory role in the Wnt pathway. In unstimulated cells, GSK-3β 
phosphorylates the N-terminal domain of β-catenin, thereby targeting it for 
ubiquitylation and proteasomal degradation. Exposure of cells to Wnts leads to 
inactivation of GSK-3β through an as yet unclear mechanism. The 
phosphoprotein Dishevelled is required, after receptor-ligand interaction, to 
transduce the signal that results in the inactivation of GSK-3β. As a result, β-
catenin is dephosphorylated [van Noort, et al. 2002] and escapes the 
ubiquitylation-dependent destruction machinery. Unphosphorylated β-catenin 
accumulates in the cytoplasm and translocates to the nucleus, where it can 
associate with the TCF/LEFs and become a transcriptional transactivator. 
Mutations in β-catenin that prevent its phosphorylation by GSK-3β (gain-of-
function mutations) have been found in cancers of the skin, colon, prostate, 
liver, endometrium and ovary [Polakis 2000].  
Many components of the Wnt pathway, and their 
functional roles, were first identified in studies of Wnt pathway in Drosophila 
melanogaster, which is driven by the Wnt homologue, Wingless [Dierick and 
Bejsovec 1999, Manoukian and Woodgett 2002]. In Drosophila, the GSK-3β 
homologue is termed Shaggy [Bourouis, et al. 1990] or Zeste-white3 
[Siegfried, et al. 1990]. Phosphorylation of β-catenin by GSK-3β occurs in a 
complex sometimes referred as “destruction complex”, which consists 
minimally of the proteins GSK-3, β-catenin, axin/conductin and adenomatous 
polyposis coli (APC) [Hinoi, et al. 2000]. APC is a tumour suppressor protein 
commonly deleted in familial adenomatous polyposis and sporadic colorectal 
cancer [Polakis 1997]. Axin (and a related protein known as conductin or axil) 
harbours several protein-protein interaction domains and serves as a 
scaffolding protein that holds together the elements of the β-catenin destruction 
complex. Both Axin and APC are phosphorylated by GSK-3β. Phosphorylation 
of axin by GSK-3β increases its stability and binding to β-catenin [Yamamoto, 
et al. 1999]. Phosphorylation of APC increases its binding to β-catenin 
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[Rubinfeld, et al. 1996]. It was determined that β-catenin is also a primed 
substrate for GSK-3β, with casein kinase I (CKI) acting as the priming kinase 
[Amit, et al. 2002]. CKI phosphorylates S45, which lies four residues C-
terminal to three GSK-3β targets at serines S33, S37 and S41. As a priming 
kinase, CKI functions as a negative regulator of Wnt signaling since it 
promotes GSK-3β function. CKI binds to axin and Dishevelled and 
phosphorylates not only β-catenin but also axin, Dishevelled and APC. 
Stimulation of cells with insulin causes inactivation of GSK-3β through a 
phosphoinositide 3-kinase (PI 3 kinase)-dependent mechanism. PI-kinase-
induced activation of PKB (also termed Akt) results in PKB phosphorylation of 
both GSK-3β isoforms (S9 of GSK-3b; S21 of GSK-3a) [Cross, et al. 1995], 
inhibiting its activity. This leads to the dephosphorylation of substrates 
including glycogen synthase and eukaryotic protein synthesis initiation factor-
2B (eIF-2B), resulting in their functional activation and consequent increasing 
of glycogen and protein synthesis [Cohen, et al. 1997].  
Numerous other stimuli also lead to inactivation of GSK-
3β through S9/S21 phosphorylation, including growth factors such as EGF and 
PDGF that stimulate the GSK-3β-inactivating kinase p90RSK (also known as 
MAPKAP-K1) through MAP kinases [Brady, et al. 1998], activators of p70 
ribosomal S6 kinase (p70S6K) such as amino acids [Terruzzi, et al. 2002], 
activators of cAMP-activated protein kinase (PKA) [Tanji, et al. 2002] and 
PKC activators [Fang, et al. 2002]. Insulin induces an increased activity of 
glycogen synthase but has no influence on the protein level of β-catenin. In 
contrast, Wnt increases the cytosolic pool of β-catenin but not glycogen 
synthase activity. Unlike insulin, neither the phosphorylation status of the 
serine9 residue of GSK3β nor the activity of protein kinase B is regulated by 
Wnt. Although the decrease in GSK3β activity is required, GSK3β is not a 
limiting component for Wnt signaling in the cells. The axin-conductin 
complexed GSK3β is dedicated to Wnt rather than insulin signaling. Insulin 
and Wnt pathways regulate GSK3b through different mechanisms, and 
therefore lead to distinct downstream events [Ding, et al. 2000].  
An increase in Wnt/β-catenin signaling is likely to be 
biologically significant, as it has been associated with maintenance of 
keratinocytes in their stem cell compartment [Zhu and Watt 1999] and a 
number of malignancies, including hair follicles tumor formation [Gat, et al. 
1998]. Efforts to understand how the keratin genes are differentially regulated 
led to the discovery that hair shaft Ha/Hb keratin genes are genuine Wnt target 
genes, and that Wnt signaling has a crucial role in the differentiation of matrix 
cells along a hair shaft lineage [Merrill, et al. 2001]. Finally the Wnt is one of 
most important pathway involved in the follicle stem cell activation: 
stabilization of β-catenin promotes anagen and hair cycle progression [Fuchs 
2007]. Wnt deregulation leads to an imbalance of proliferation and 
differentiation, often resulting in cancers [Reya, et al. 2001]. β-catenin controls 
lineage selection of epidermal stem cells: high levels of β-catenin activation 
favours hair follicle differentiation, whereas inhibition of activation favours 
interfollicular epidermal differentiation [Fuchs, et al. 2004, Niemann and Watt 
2002] 
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Fig 4.  Canonical Wnt pathway (A) and GSK3  β  regulation (B).   (A) 
Protein complex formed by axin, APC, GSK-3β, and CK1α (named β-catenin 
destruction complex) binds to β-catenin in the absence of Wnt, resulting in the 
degradation of β-catenin by 26S proteasome system. WIF1 and sSFRPs can work as 
endogenous inhibitors of the Wnt signaling pathway (left). When Wnt binds to the 
receptor Fz and co-receptor LRP5/6, these receptors mediate signals into cells and 
inhibit the function of β-catenin destruction complex. Accumulated-β-catenin in the 
cytoplasm translocates to nucleus. In the nucleus, β-catenin activates the transcription 
of target genes together with transcription factors (TCF/LEF) and other transcriptional 
cofactors, such as CBP. (Taken from Takahashi-yanga e Kahn, Clinical Cancer 
Research, 2010). (B) Regulation of GSK-3β activity by serine phosphorylation. In the 
resting cell, GSK-3β is constitutively active. Both unprimed substrates and substrates 
phosphorylated by a priming kinase (PK) are capable of being phosphorylated by the 
active GSK-3b. The priming phospho-residue at position N + 4, binds a pocket of 
positive charge arising from the arginine (R) and lysine (K) residues indicated. This 
directs a serine or threonine at position N to the active catalytic site (C.S.). When an 
inactivating kinase (IK) such as PKB/Akt phosphorylates GSK-3b on serine 9 (S9), 
the phosphorylated Nterminus becomes a primed pseudo-substrate that occupies the 
positive binding pocket and active site of the enzyme, acting as a competitive inhibitor 
for true substrates. This prevents phosphorylation of any substrates. (Modified from 
Bradley and Woodgett, journal of cell science 2003) 
 
 
1.4.GSK 3β  
 
Glycogen synthase kinase 3β (GSK-3β) is a 
serine/threonine kinase that was first isolated and purified as an enzyme 
capable of phosphorylating and inactivating the enzyme glycogen synthase 
[Embi, et al. 1980, Woodgett and Cohen 1984]. GSK-3β acts as a downstream 
regulatory switch that determines the output of numerous signaling pathways 
initiated by diverse stimuli. GSK-3β regulates several physiological responses 
in mammalian cells, including protein synthesis, gene expression, subcellular 
localization of proteins, and protein degradation, in mammalian cells by 
phosphorylating many substrates [Frame and Cohen 2001, Grimes and Jope 
2001, Woodgett 2001].  
A B 
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The pathways in which GSK-3β acts as a key regulator, 
when dysregulated, have been implicated in the development of human 
diseases such as diabetes, Alzheimer’s disease, bipolar disorder and cancer. 
Evidence that GSK-3β regulates cellular architecture in neuronal cells has been 
accumulated [Cohen and Frame 2001, Jope and Johnson 2004]. Two 
microtubule-associating proteins, Tau and MAP1B, are phosphorylated by 
GSK-3β, which regulates their binding to microtubules, thereby modulating 
microtubule dynamics. An inactive pool of GSK-3β has been found to be 
localized at the leading edge of the cells alongside F-actin, and semapholin 3A 
and lysophosphatidic acid activate GSK-3β, causing growth cone collapse and 
neurite retraction [Eickholt, et al. 2002]. GSK-3β mediates Par6-PKCζ-
dependent promotion of polarization and cell protrusion in astrocytes [Etienne-
Manneville and Hall 2003]. Furthermore, GSK-3β phosphorylates CRMP2 to 
specify the fate of axons and dendrites [Yoshimura, et al. 2005]. GSK-3β has 
also been shown to be involved in signaling activated by cell adhesion in 
nonneuronal cells [Ouatas, et al. 2003, Roberts, et al. 2004]. The formation of 
extending lamellipodia in migrating keratinocytes is blocked by GSK-3β 
inhibitors [Koivisto, et al. 2003]. The initiation and stimulation of sperm 
motility are accompanied by the inactivation of GSK-3β [Somanath, et al. 
2004]. Although these results suggest that GSK-3β is involved in the dynamics 
of actin filaments and microtubules, how the GSK-3β activity is linked to 
molecules involved in cell migration is not clearly understood.  
 
In literature there is more than one evidence  of a 
crosstalk regulation between the Wnt signaling and other pathways. In 
particular, Wnt signaling is suppressed by Notch1 activation, and is elevated in 
keratinocytes and tumors as a consequence of loss of Notch1 function [Nicolas, 
et al. 2003].  
 
 
1.5.Notch signaling 
 
Notch signaling controls numerous cell-fate specification 
events in multicellular organisms, and dysregulated Notch signaling causes 
several diseases with underlying developmental defects. In vertebrates, Notch 
signaling has been implicated in many such patterning events as diverse as 
inner ear hair cell formation, insulin secreting pancreatic β cell production, 
specification of crypt and goblet cells in the intestine, and multiple steps of B 
and T cell development within the immune system [Apelqvist, et al. 1999, 
Lanford, et al. 1999, Robey, et al. 1996, van Es, et al. 2005, Washburn, et al. 
1997]. Proper tissue development also requires that fine-scale cellular 
differentiation is coordinated with the overall control of tissue size and 
identity, and Notch signaling is widely implicated in many fundamental 
regulatory processes, including cell proliferation, apoptosis, and the epithelial-
mesenchymal transition in higher eukaryotes. 
Indeed, it might not be an exaggeration to suggest that 
nearly all cells of complex animal tissues could potentially require Notch 
signaling at some point or points in their lineage histories for proper final 
differentiation. Given the wide-ranging importance of Notch signaling during 
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animal development, it is not surprising that mutations in genes encoding 
Notch signaling components have been implicated in several human diseases 
involving aberrant cellular differentiation or tissue development, including T 
cell acute lymphoblastic leukemia (T-ALL), Alagille syndrome, spondylocostal 
dysostosis, tetralogy of Fallot, CADASIL syndrome, and aortic valve disease 
[Artavanis-Tsakonas, et al. 1999, Gridley 2003]. In such contexts Notch 
signaling most typically controls the fine cellular patterning and allocation of 
different cell types within a tissue. Accordingly, Notch signaling depends upon 
direct contact between the interacting cells. Furthermore, as Notch-dependent 
patterning events often occur over relatively brief developmental time spans, 
signal transmission must be both rapid and highly responsive to 
downregulation and reactivation. The core molecular features of Notch 
signaling as well as its regulation by a host of posttranslational processes allow 
the pathway to operate with exquisite spatiotemporal sensitivity and versatility 
in a wide variety of developmental contexts.  
The term ‘‘Notch signaling’’ is generally understood to 
refer to a specific molecular mechanism that is highly conserved among many 
organisms and is the best characterized mode of Notch signaling. This 
mechanism is also referred to as ‘‘canonical Notch signaling”, to distinguish it 
from some atypical signaling modes that have also been documented. 
Canonical Notch signaling involves activation of  Notch receptor at cell surface 
by ligands of the DSL family, which includes Delta and Serrate/Jagged in 
Drosophila and mammals as well as LAG-2 in C. elegans. Members of both 
Notch receptor and DSL ligand families are, for the most part, type I single-
pass integral membrane proteins with extracellular domains consisting 
primarily of up to 36 tandem EGF-like repeats [Wharton, et al. 1985, Yochem 
and Greenwald 1989]. Receptor-ligand interactions involve direct binding of 
an N-terminal ligand domain to the EGF-like repeat 11-12 region of Notch 
[Rebay, et al. 1991]. Notch signal transduction is initiated by ligand binding 
and endocytosis, which generate the forces needed to expose an otherwise 
inaccessible cleavage site in the extracellular portion of the Notch C-terminal 
fragment. Cleavage at this site produces the activated, membrane-anchored 
Notch form termed Notch extracellular truncation (NEXT). NEXT is 
subsequently cleaved by the intramembrane aspartyl protease complex γ-
secretase, leading to release of the Notch intracellular signal-transducing 
fragment termed Notch intracellular domain (NICD) [Bray 2006, Gordon, et al. 
2007]. This cleavage can occur at the cell surface and within the endosomal 
trafficking pathway. In the absence of NICD, most Notch target genes are 
maintained in an actively repressed state through the formation of 
transcriptional complexes involving CSL transcription factors and various co-
repressors (CoRep). NICD possesses nuclear localization sequences [Stifani, et 
al. 1992] and enters  into the nucleus where it participates directly in the 
transcriptional regulation of target genes [Struhl and Adachi 1998]. Upon 
nuclear translocation of NICD, corepressors associated with CSL are displaced 
and a transcriptionally active complex consisting of CSL, NICD, Mastermind 
(Mam), and coactivators (CoAct) assembles, leading to activation of Notch 
target genes.  
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Fig 5.   Notch Receptor Synthesis and Activation.  The Notch receptor is 
synthesized as a 300 kDa precursor that is processed and glycosilated in the Golgi, 
until his exposure on the cell surface. Notch signal transduction is initiated by ligand 
binding and endocytosis, which generate the forces needed to expose an otherwise 
inaccessible ADAM10/TACE/Kuz/SUP-17 cleavage site in the extracellular portion 
of the Notch C-terminal fragment. Cleavage at this site produces the activated, 
membrane-anchored Notch form termed Notch extracellular truncation (NEXT). 
NEXT is subsequently cleaved by the intramembrane aspartyl protease complex γ-
secretase, leading to release of the Notch intracellular signal-transducing fragment 
termed Notch intracellular domain (NICD). This cleavage can occur at the cell surface 
and within the endosomal trafficking pathway. In the absence of NICD, most Notch 
target genes are maintained in an actively repressed state through the formation of 
transcriptional complexes involving CSL transcription factors and various co-
repressors (CoRep). Upon nuclear translocation of NICD, corepressors associated with 
CSL are displaced and a transcriptionally active complex consisting of CSL, NICD, 
Mastermind (Mam), and co-activators (CoAct) assembles, leading to activation of 
Notch target genes. This schematic presents a simplified overview of the main 
conserved features of Notch synthesis and signaling; details of the biochemical 
mechanisms involved are omitted for the sake of clarity, the positions of the Notch 
diagrams are not intended to accurately depict the topology of Notch in various 
membrane compartments, and the glycosylation symbols and transcriptional complex 
diagrams are illustrative and do not imply specific glycosylation site locations or 
protein-protein interactions. (Taken from Fortini, Cell 2011). 
 
 
 
The rapidly changing levels of pathway activity require 
that the nuclear effectors do not have a long half-life. This is achieved by 
recruitment of factors such as cyclin-dependent kinase-8 (CDK8), which 
phosphorylates NICD, rendering it into a substrate for the nuclear ubiquitin 
ligase SEL10 [Fryeret al., 2002, Fryer et al.,2004]. In mammalian cells, SEL10 
     21 
preferentially interacts with a phosphorylated form of NICD and the expression 
of a dominant negative SEL10 leads to increased expression of Notch targets 
[Gupta-Rossi, et al. 2001, Oberg, et al. 2001]. This interaction requires the C-
terminal PEST region, consistent with observations that Notch with C-terminal 
truncations behave as gain-of-function alleles, and in humans they contribute to 
oncogenicity [Weng, et al. 2004].  The best characterized Notch targets are the 
bHLH genes of the HES/HEY families, exemplified by the E(spl) genes in 
Drosophila and HES1 in mouse. Their expression is usually transient and 
reflects the dynamic nature of Notch signaling. In addition there is evidence for 
autoregulation such that oscillations of HES expression have been observed 
and are thought to contribute to clocks that regulate somitogenesis, limb 
segmentation, and neural progenitor maintenance [Brend and Holley 2009, 
Kageyama, et al. 2007, Lewis, et al. 2009, Shimojo, et al. 2008]. Altogether 
HES/HEY have now been shown to function downstream of Notch in many 
critical processes and to contribute to oncogenesis. All HES/HEY proteins 
appear to function as transcriptional repressors. 
In the human epidermis, Notch1 is expressed in all the 
epidermal layers; Notch2 is expressed in the basal layer. In the mouse 
epidermis, however, Notch1 is expressed most strongly in the spinous layer, 
and Notch2 is also expressed in the spinous layer but not in the basal layer 
[Blanpain, et al. 2006]. Notch ligands such as Jagged and Delta-like family 
members are expressed in overlapping patterns with Notch in the epidermis 
both of humans and mice [Rangarajan, et al. 2001]. 
Notch1 signaling in mouse keratinocytes stimulates 
expression of early differentiation markers such as keratin1 and involucrin. 
This induction is consistent with the epidermal phenotype observed in mice 
that have constitutively activated Notch1 in the epidermis. Histologically, the 
Notch1 activated mice show acanthosis, corresponding to an increase in the 
differentiating (keratin1 positive) cell compartment of the epidermis [Blanpain, 
et al. 2006]. Conversely a decrease in the differentiating cell compartment is 
observed in mice that have a keratinocyte specific deletion of the Notch1 gene 
[Rangarajan et al., 2001]. A substantial increase in the number of layers of 
proliferating cells occurs in the Notch1 deficient epidermis. Recent studies 
show that Notch signaling determines spinous cell fate and induces terminal 
differentiation by a mechanism independent of Hes1, but Hes1 is required for 
maintenance of the immature state of spinous cells. Notch signaling induces 
Ascl2 expression to promote terminal differentiation, while simultaneously 
repressing Ascl2 through Hes1 to inhibit premature terminal differentiation. A 
Notch1/Notch2 double knock out mice model at embrional stage E18.5 shows 
a thinner epidermal phenotype: K10-positive suprabasal layer cells were 
selectively reduced indicating that Notch signaling is required for the 
generation and/or maintenance of suprabasal cells during epidermal 
development. K15, a marker for basal layer cells at this stage of epidermal 
development, was exclusively expressed in basal layer cells. By contrast, the 
N1N2 dcKO epidermis shows a pronounced number of K15-positive/K10-
negative cells in the lowermost suprabasal layer, suggesting retardation of 
spinous cell differentiation. Furthermore, a significant reduction in loricrin 
expression was observed in the N1N2 dcKO epidermis, indicating an important 
role of Notch signaling in granular cell differentiation [Moriyama, et al. 2008].  
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First, Notch has been found to directly regulate genes 
involved in proliferation and apoptosis. For example a direct targets of Notch 
involved in promoting proliferation include CyclinD [Jeffries, et al. 2002, 
Joshi, et al. 2009], string/CDC25 [Krejci, et al. 2009, Palomero, et al. 2006], 
and CDK5 [Palomero, et al. 2006]. The keratinocyte-specific deletion of the 
Notch1 gene results in marked epidermal hyperplasia and deregulated 
expression of multiple differentiation markers. In differentiating primary 
keratinocytes in vitro endogenous Notch1 is required for induction of 
p21WAF1/Cip1 expression, and activated Notch1 causes growth suppression 
by inducing p21WAF1/Cip1 expression. Activated Notch1 also induces 
expression of ‘‘early’’ differentiation markers, while suppressing the late 
markers like loricrin and filaggrin. Induction of p21WAF1/Cip1 expression 
and early differentiation markers occur through two different mechanisms. The 
RBP-Jk protein binds directly to the endogenous p21 promoter and p21 
expression is induced specifically by activated Notch1 through RBP-Jk-
dependent transcription. Expression of early differentiation markers is RBPJk-
independent and can be induced by activated Notch1 and Notch2, as well as 
the highly conserved ankyrin repeat domain of the Notch1 cytoplasmic region. 
Thus, Notch signaling triggers two distinct pathways leading to keratinocyte 
growth arrest and differentiation [Rangarajan, et al. 2001]. Phosphorylated 
forms of NICD1 have been identified within the nucleus [Redmond, et al. 
2000, Shimizu, et al. 2000]and have been correlated with CSL members [Foltz 
and Nye 2001, Kidd, et al. 1998], as well as correlated with regions of the 
receptor that are required for activity [Foltz and Nye 2001, Ingles-Esteve, et al. 
2001].  
Genetic studies have suggested that the Drosophila 
homolog of glycogen synthase kinase-3β (GSK-3β), Shaggy, may act as a 
positive modulator of the Notch signaling [Ramain, et al. 2001, Ruel, et al. 
1993]. Foltz and colleagues have shown that GSK-3β was able to bind and 
phosphorylate NICD1 in vitro, and attenuation of GSK3β activity reduced 
phosphorylation of NICD1 in vivo. Functionally, ligand-activated signaling 
through the endogenous Notch1 receptor was reduced in GSK3β null 
fibroblasts, implying a positive role for GSK3β in mammalian Notch signaling. 
As a possible mechanistic explanation of the effect of GSK3β on Notch 
signaling, they observed that inhibition of GSK3β shortened the half-life of 
NICD1. Conversely, activated GSK3β reduced the quantity of NICD1 that was 
degraded by the proteasome. These studies reveal that GSK3β modulates 
Notch1 signaling, possibly through direct phosphorylation of the intracellular 
domain of Notch, and that the activity of GSK3β protects the intracellular 
domain from proteasome degradation. 
Notch signaling has an important gate keeper function in 
the transition from basal to suprabasal cells of epidermis; in mammalian cells, 
Notch activation is generally thought to maintain stem cell potential and inhibit 
differentiation, thereby promoting carcinogenesis [Artavanis-Tsakonas, et al. 
1999]. However, in specific cell types such as keratinocytes, increased Notch 
activity causes exit from the cell cycle and commitment to differentiation 
[Lowell, et al. 2000, Nickoloff, et al. 2002, Rangarajan, et al. 2001]. In mouse 
keratinocytes, the gene for the cyclin/CDK inhibitor p21WAF1/Cip1 is also 
induced by the Notch/RBP-Jk complex through both a direct and indirect 
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mechanism [Mammucari, et al. 2005, Rangarajan, et al. 2001], with 
p21WAF1/Cip1 functioning downstream of Notch, as a negative 
transcriptional regulator of Wnt4 expression [Devgan, et al. 2005]. Notch 
activation also exerts effects on other pathways important to keratinocyte 
growth and differentiation; it induces NF-κB [Nickoloff, et al. 2002] and 
inhibits AP-1 [Chu, et al. 2002] and β-catenin signaling [Devgan, et al. 2005, 
Nicolas, et al. 2003]. Biologically, both Notch1 [Lowell, et al. 2000] and p21 
[Topley, et al. 1999] have been reported to promote the commitment of 
keratinocyte stem cell populations to differentiation [Missero, et al. 1996, 
Nicolas, et al. 2003, Topley, et al. 1999]. Beside p21, Notch signaling affects 
other pathways with significant regulatory functions in keratinocyte growth 
and differentiation [Lefort and Dotto 2004]. Moreover, Notch1 signaling was 
found to activate caspase 3, thereby leading to a decrease in proliferation and 
an increase in the differentiation of embryonic keratinocytes through activation 
of PKC-δ [Okuyama, et al. 2004]. Recent work on Notch shows that Notch1 
gene expression and activity are substantially down-modulated in keratinocyte 
cancer cell lines and tumors, and that Notch1 gene is a p53 target in human 
keratinocytes with a role in tumor suppression [Lefort, et al. 2007]. Indeed in 
mouse model ablation of Notch1 results in epidermal and corneal hyperplasia 
followed by the development of skin tumors and facilitated chemical-induced 
skin carcinogenesis.  
 
 
 
1.6.Psoriasis 
 
Psoriasis is a relatively common skin disease affecting 
1% to 2% of the population the main feature of psoriasis is a red scaly area or 
patch. The patches appear particularly on the knees, elbows and scalp and 
sometimes on other parts of the trunk, and legs. Histological the chronic 
lesions demonstrate epidermic hyperplasia, parackeratosis, desquamation and 
small abscesses of neutrophils in epidermis. Types of psoriasis include plaque, 
guttate, erythrodermic and pustular [Peters, et al. 2000]. Males and females are 
equally affected and 75% of patients develop the disease before the age of 40. 
First manifestations of the disease are most common in the third decade. Two 
peaks of age of onset have been described: one at 20–30 years and a smaller 
peak at 50–60 years. Psoriasis can also occur with other inflammatory diseases 
such as (psoriatic) arthritis in 10–30%. Psoriasis also occurs in association with 
human immunodeficiency virus (HIV) infection. It is hypothesized that 
psoriasis is due to a combination of genetic predisposition and environmental 
assaults. These can include injury, infection, stress or certain medications.  
The pathogenesis of inflammatory diseases such as 
psoriasis involve a large number of deregulated genes and gene clusters, 
particularly those involved in epithelial proliferation and in the immune 
system. However, these studies have not provided sufficient insights to lead to 
an identification of the molecular defects underlying the disease. The normal 
cycle of maturation of keratinocytes is 28–30 days. In psoriasis this is 
accelerated to 3–4 days. The immune system has been strongly implicated in 
the pathogenesis of psoriasis since it resembles a T cell-mediated autoimmune 
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disease [Gottlieb 2001]. During lesion formation, inflammation precedes 
epidermal hyperproliferation and increased numbers of T cells have been 
demonstrated in the uninvolved skin of psoriatic patients [Baadsgaard, et al. 
1990].  
The genome–wide linkage scans have identified Multiple 
loci linked to disease and revealed overlap with psoriasis susceptibility loci on 
chromosomes 1q21 (PSORS4), 3q21 (PSORS5), 17q25 (PSORS2) and 
20p12.a strong HLA-C association is described (PSORS1). The peak of 
linkage of Atopic Dermatitis and psoriasis on chromosome 1q21 overlies the 
human epidermal differentiation complex (EDC) that spans a region of ~2 Mb 
[Mischke, et al. 1996]. The genes of the EDC are expressed late during 
maturation of epidermal cells [Hardas, et al. 1996]. The causes of psoriasis are 
unknown to date.  
There are many pathways resulting up or downregulated 
in these diseases. Several studies have demonstrated that VEGF expression is 
increased in lesional psoriatic skin, that the serum levels of circulating VEGF 
protein are significantly elevated in patients with severe disease, and that 
VEGF serum levels were directly correlated with disease activity [Bhushan, et 
al. 1999, Creamer, et al. 1996, Hardas, et al. 1996, Nielsen, et al. 2002]. A 
major role of VEGF in the pathogenesis of psoriasis was further corroborated 
by the phenotype of transgenic mice with epidermis-specific overexpression of 
VEGF. VEGF transgenic mice show enhanced skin vascularity and vascular 
permeability [Detmar, et al. 1994]. At about 6 months of age, these mice 
spontaneously develop chronic inflammatory skin lesions that histologically 
closely resemble human psoriasis [Xia, et al. 2003]. To monitoring 
angiogenesis in vivo, it was created a transgenic mouse, Vegfr2-luc, in which a 
luciferase reporter is under the control of  murine VEGFR2 promoter and 
allowing to follow the Vegfr2 promoter switch on by in vivo bioluminescence 
[Zhang, et al. 2004].  
The Wnt signaling pathway, was found to strongly up-
regulate VEGF [Zhang, et al. 2001]. There are strong evidence that the Wnt 
pathway is up-regulated in psoriasis: the expression of Wnt5a was 4-fold 
higher in lesional skin compared to normal skin sample of the same patient 
[Reischl, et al. 2007]. Moreover there is evidence that some keratinocyte 
differentiation events are controlled by changes in cell–cell adhesion. β-catenin 
has a dual function as a component of intercellular adherents junctions and also 
as a transcription factor as part of the Wnt signaling pathway. β-catenin is not 
required for keratinocyte proliferation but has been shown to regulate 
keratinocyte stem cells and hair follicle morphogenesis. In psoriatic skin was 
observed a strong nuclear localization of β-catenin in suprabasal layers. 
Moreover was observed a marked decrease in membranous β-catenin and 
increased cytoplasmic β-catenin at the same level as the nuclear β-catenin. In 
the uninvolved psoriasis samples there was some nuclear β-catenin but this was 
much less than in involved psoriasis [Hampton, et al. 2007]. Moreover defects 
in the Notch pathway are thought to be involved in the pathogenesis of 
psoriasis. In the skin, Notch1 has a role in promoting keratinocyte 
differentiation. In recent years, increasing evidence suggests that Notch may 
play a key role in linking the control of epidermal proliferation and 
differentiation. Furthermore, aberrant Notch signaling might contribute directly 
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to the pathogenesis of skin diseases like psoriasis and Basal Cell Carcinoma. 
Notch and Delta signaling molecules are up-regulated in the basal and 
differentiating layers of adult human epidermis, whereas they are under-
expressed in disorganised proliferating epidermis. The specific differentiation 
programme that keratinocytes undergo in skin is under their control. The 
alteration of the Notch pathway play a role in disrupting the keratinocyte 
differentiation programme, leading to unorganised suprabasal epidermal strata 
and dermal invasion [Thelu, et al. 2002]. Recent advances in the study of 
Notch signaling have confirmed that there is crosstalk between the Notch 
signaling pathway and a variety of other signaling molecules Wnt  β-catenin 
and the p53 family member, p63. The absence of Notch activity allows Wnt  
signaling to persist in a tissue where they are normally repressed [Nicolas, et 
al. 2003]. In addition, Notch counteracts the action of p63 to maintain 
immature cell characteristics. 
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2.AIM OF THE STUDY  
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To better understand the biological function of Prune in 
vivo system, during my Ph.D. work I focused my research interest in the 
attempt to characterize the transgenic mice overexpressing h-Prune into skin. 
The purpose of our study was to understand the role of h-Prune in epidermal 
proliferation and keratinocyte-differentiation using a transgenic mouse model, 
already present in the laboratory of professor Zollo, in which the transgenic 
protein expression was driven by a modified Loricrin promoter (ML) obtaining 
a specific epidermal increase of  the protein of interest [Waikel, et al. 1999]. 
First we wanted to characterize the phenotypic changes 
carried by h-Prune overexpression in the mouse epidermis.  
H-Prune protein is known to date to stimulate cellular 
motility and metastasis process in a breast cancer model [D'Angelo, et al. 
2004]. The role of h-Prune in the increased cell motility can be explained in 
part to h-Prune interaction with GSK-3β with which cooperatively works to 
regulate the disassembly of focal adhesions and promote cell migration 
[Kobayashi, et al. 2006]. GSK-3β covers a fundamental role like key effector 
of the canonical Wnt pathway (Wnt/β-catenin signaling). Wnt signaling 
deregulation leads to an imbalance of proliferation and differentiation program 
[Reya, et al. 2001] 
Based on these assumptions we wanted to investigate the 
effect of h-Prune on GSK-3β downstream regulated genes (canonical Wnt 
pathways related genes). Due to GSK-3β and h-Prune promote cell motility, 
we expected that the resulting phenotype of our transgenic mice was related to 
an hyperproliferation and/or would lead to the defect in keratynocites 
differentiation program. 
Since h-Prune in combination with GSK-3β increased 
the cell motility, we wanted to analyze h-Prune expression levels in an 
hyperproliferative/inflammatory skin disease like Psoriasis. In such disease 
infact the basal keratynocytes increase their motility migrating to the outer 
layer of epidermis. 
Finally we want to find similarities between the 
molecular mechanisms activate by h-Prune overepression in the skin, in the 
ML-h-Prune transgenic mice and the known defects of signaling pathways 
which are normally deregulated in the human psoriasis, a multigenetic disorder 
which show both hyperproliferation,  migration  and a pro-inflammatory 
phenotypes. 
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3.MATERIALS AND METHODS 
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3.1.ML-h-Prune transgenic mice genotyping  
 
PCR amplification was used to genotype mice by 
detection of sequences not normally present in the murine genome. The 
amplified segment of DNA, was detected by agarose gel electrophoresis. The 
genomic DNA was prepared by digesting mouse tails with 1.5 µg/ml 
proteinase K (Promega) in 200 µl DNA extraction buffer containing 50 mM 
Tris pH 8; 100 mM EDTA; 100 mM NaCl; 1% SDS, overnight at 55 °C in a 
termoblock. The genomic DNA was extracted with phenol/chloroform solution 
and precipitated with isopropyl alcohol. DNA was resuspended in 50 µl TE 
buffer (Invitrogen) and stored at +4 °C. The PCR reaction was performed using 
2 µl (100 ng/µl) DNA in 50 µl of reaction buffer containing 20 µl of 2.5x 
Master Mix (5Prime Eppendorf) and 400 nM each primers (sense and 
antisense). Following primers were used: M-Loricrin forward: 5'-AGG AAT 
GGA ACA GTC CAG C-3', H-Prune reverse: 5'-GCT CGA GTC TGG GGT 
GAT CT-3', which amplify a fragment of about 500 bp. The samples for PCR 
amplification were prepared using a laminar flow hood to avoid contamination. 
The reaction was carried out as follows: initial denaturation of 5 min at 94 °C 
and 35 cycles of amplification. Each cycle consists of a denaturation step of 30 
sec at 94 °C, an annealing of 45 sec at 55 °C, and extension of 1 min at 72 °C; 
the extension was prolonged for 10 min during the last cycle. 
 
 
3.2.Protein extraction and western blot analysis 
 
The cells were washed with PBS and lysed directly on 
ice for 30 minute with a RIPA buffer containing 1% NP40, 50 mM Tris-HCl 
pH 8, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 1x protease 
inhibitors (Roche Applied Science) and sodium orthovanadate (SIGMA). For 
lysates derived from skin, tissue were removed from 5-days old mice. Dermal 
epidermal separation was obtained dipping the removed skin in PBS1x at 60°C 
for 1’, followed to a rapid passage in PBS1x placed in ice. The epidermis was 
finally slowly pulled from the dermis using a tweezer.  The samples were 
homogenized by using TissueLyser (QIAGEN) at a frequency of 30 Hz for 1 
minute. To allow the homogenization of tissue, beads were inserted into the 2 
mL tube containing the sample and RIPA buffer. To detect the relative levels 
of protein quota we used the following antibodies: h-Prune monoclonal 
antibody (able to recognize both human and murine Prune protein), anti-β-
catenin and anti-Filaggrine (BD Biosystems), anti-activated-β-catenin 
(Millipore), anti-β-actin (Sigma), Hes 1 and Cyclin D1 (Santacruz 
Biotechnology),  p21, Cytokeratin 15, Cytokeratin 14, Cytokeratin 16, NICD1, 
total GSK-β, Ser9-P-GSK3β and Hey1 (abcam)  and horse-radish peroxidase-
conjugated anti-mouse and anti-rabbit secondary antibodies (GE Healthcare 
Life Sciences, Milan,Italy). 
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3.3.Histological and Immunohistochemical analysis .  
 
Skin samples from transgenic littermate mice were fixed 
in PBS-buffered 4% paraformaldehyde for 16 hours and then dehydrated 
before embedding into paraffin. Embedded skin samples were sectioned (7µm) 
and deparaffinized in Bio-Clear (Bio Optica) for 15 minutes. Samples were 
rehydrated by using a scalar concentration of ethyl alcohol (100%, 90% and 
70% of ethyl alcohol) and were stained with haematoxylin and eosin (H&E) or 
analyzed by immunohistochemistry. Haematoxylin and eosin staining, skin 
samples after rehydratation were washed in distillated water and staining in 
Harris haematoxylin solution for 8 minutes. After washing in running tap water 
for 5 minutes, samples were differentiated in 1% acid alcohol for 30 seconds 
and washed again in running tap water for 1 minute. Skins were washed with a 
0.2% ammonia solution for 30 seconds to 1 minute and, after it have been 
washed with running tap water for 5 minutes, were rinsed in 95% ethyl alcohol 
10 dips. Counterstain was made in eosin-phloxine solution for 30 seconds to 1 
minute. After dehydratation through 95% ethyl alcohol and 2 changes of ethyl 
absolute alcohol, from 5 minutes each, skin samples were cleared in Bio-Clear 
(Bio Optica ) and mounted with Eukitt (Bio Optica). Immunohistochemical 
analysis was performed using Vectastain Elite ABC Kit (Vector Laboratories 
Inc.) according to the manufacturer’s instructions. Sections were pre-treated in 
a microwave oven for 5 minutes at high energy and for 15 minutes at low 
energy in 10 mM Na Citrate (pH 6.0). The prune monoclonal antibody (Anti-
Prune) was used at dilution 1:1000 for mouse tissues and 1:500 for human 
skin. Colorimetric reactions were carried out using DAB (Vector, Vector 
Laboratories Inc.) according to the manufacturer’s instructions.  
 
 
3.4.Measurement of epidermal thickness 
 
The quantification of the interfollicular epidermal 
thickness of ML-h-Prune mice was performed by measuring the distance 
between the basal layer and granular layer. In each experiment were analyzed 
three different mice per genotype, measuring ten regions per mouse. 
 
 
3.5.Skin permeability assay. 
 
This assay is based on skin barrier-dependent penetration 
by histological dyes. The basis of this skin modification is unknown but is 
likely to involve extraction of polar lipid [Wertz and Downing 1987]. Unfixed, 
untreated embryos were incubated for 1-5 minutes (45 minutes for 6 days old 
mice) in methanol and rinsed in PBS, followed by incubation in  0.1% 
toluidine blue. After staining, embryos were photographed using a Zeis Stemi 
SV11 microscope with transmitted and surface illumination. For the 6-days old 
mice photographs were taken with a simple camera placing the mice on a white 
background. Scanned images were processed with Adobe Photoshop. 
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3.6.Cell culture and transfection 
 
HaCat cells, a spontaneously immortalized human 
epidermal keratinocyte cell line grown at 37°C under 5% CO2 in Dulbecco’s 
modified Eagles’ medium supplemented with 10% fetal bovine serum, 100 
units/ml penicillin, and 100 µg/ml streptomycin . HaCat cells were transiently 
transfected with plasmid by lipofection using TransFectin Lipid reagent 
(BioRad) according to the manufacturer’s instructions. Cells were replated 24 h 
before transfection at an optimal cell density in 10 ml of culture medium in 100 
mm tissue culture dishes. For transfection, 40 µl of TransFectin Lipid reagent 
were incubated with 15 µg of indicated plasmids, in 3 ml of serum free DMEM 
for 30 min at room temperature. Cells were transfected by changing the 
medium with 1 ml of DMEM containing the plasmids and LipoFectamine lipid 
reagent, followed by incubation at 37°C in a humidified atmosphere of 5% 
CO2 for 48 h. To have a confirmation of transfection, in each transfection mix, 
together with the plasmid transfected, 700 ng of pEGFP vector was 
cotrasfected with the indicated plasmid. After 48 h of incubation at 37°C in a 
humidified atmosphere of 5% CO2 the GFP was detected by a fluorescence 
microscope. 
 
3.7.Tissue RNA extraction. 
 
The animals were sacrificed by CO2 saturated 
atmosphere. Immediately after death a small piece of skin (≅ 2cm) was taken 
from the back of mice using a little scissor, and epidermis was separated from 
dermis as previously described. Having obtained the mice genotype the 
epidermis were thawed in ice and the tissues were lysed by TissueLyser 
(QIAGEN), placing the single epidermis in 2ml-tube in 1ml of trizol, at a 
frequency of 30 Hz for 1 minute. The lysate was clarified by centrifugation at 
13000 g for 10 min. Supernatant was transferred to a clean tube and the total 
RNA were extracted using TRIzol reagent (Invitrogen) according to the 
manufacturer’s instructions. RNA concentration was calculated using a 
NanoDrop spectrophotometer at 260 nm absorbance. 3 µg of total extracted 
RNA was reverse transcribed with Iscript kit ( BioRad ). The cDNA was 
diluited twenty-fold prior to PCR amplification. Notch targets, Wnt targets and 
Prune levels mRNA expression were evaluated by quantitative reverse 
transcription polymerase chain reaction (RT-PCR). Reactions were performed 
in a 10 µl volume with 0,6 µM primers, 45 ng of cDNA template and SYBR 
mix (Applied Biosystems) that includes Taq DNA-pol and dNTPs. Negative 
controls included PCR reactions with cDNA omitted. Each amplification 
reaction was done in duplicate. To confirm amplification specificity, PCR 
products from each primer pair were subjected to melting curve analysis. Data 
were analyzed with ΔΔCt method. The results are presented as normalized ratio 
of the expression of specific molecule mRNA to β-Actin. The oligo sequence 
utilized for cDNA amplification are as follow:  
C-MYCforw : CTCCTCGAGCTGTTTGAAGG  
C-MYCrev:AGCAGCTCGAATTTCTTCCA  
HES1forw :TCATCCCGGTCTACACCAGC; 
HES1rev:GGAGCCACTGGAAGGTGACA 
ASCL1forw:CCTGGGAATGGACTTTGGAAG 
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ASCL1rev:TGACGTCGTTGGCGAGAAA 
mJAG1_for:GGTGGAGGCCTGGGATTC 
mJAG1_rev: TGTTTCAGTGTCTGCCATTGC 
mBirc5_for: TGTTTTTTCTGCTTTAAGGAATTGG 
mBirc5_rev:CATCTGCTTCTTGACAGTGAGGAA 
mHES5_forw:ATGCTCAGTCCCAAGGAGAAAA 
mHES5_rev :GCTCCAGCAGCAGCTTCAG 
mCycliD1_for:TCTTACTTCAAGTGCGTGCAGAA 
mCycliD1_rev:AGCGGGAAGACCTCCTCTTC 
mp27_for: ACAATCCGGCTGGGTTAGC  
mp27_rev:AACCGTCTGAAACATTTTCTTCTGT 
mK15_for:AGAGCCCAGCCAGTCCAGAT 
mK15_rew :AACGCGCGAGTTGTCAATG. 
 
 
3.8.Animal experiment.   
 
In vivo imaging was performed as previously described 
[Zhang, et al. 2004] using IVIS imaging system (Xenogen). 5-days old pups 
Vegfr2-luc/ML-Prune transgenic mice, were anesthetized with isoflurane and 
injected intraperitoneally with 150 mg/kg luciferin (D-Luciferin Firefly, 
potassium salt, Caliper Life Science). Ten minutes after luciferin injection, 
mice were imaged for 1 to 5 minutes. To quantify the bioluminescence the 
integrated fluxes of photons (phot. per sec) within an each area of interest were 
determinated using LivingImage 3.2 software (Xenogen). The data were 
analyzed using Excel software or the QuickCalc software. 
 
 
3.9.Luciferase reporter assays and TOP/FOP assay 
 
Luciferase reporter assays were performed using the 
Dual Luciferase Reporter Assay (Promega). HaCat cells and HEK293 cells 
were transfected with the PolyFect transfection Reagent (Qiagen) according to 
the manufacturer’s instructions. In brief, 2⋅105 cells/well were seeded in a 6-
well plate the day before transfection. 500 ng of luciferase reporter plasmid  
and 100 ng of pRL-CMV (Promega) were transfected. Cells after 48 hours of 
transfection with indicated vectors, were lysed with Passive Lysis Buffer 
(Promega), and Luciferase activity present in cellular lysates was assayed 
following the manufacturer’s instructions. Light emission was quantified with 
the luminometer LUMINO (Stratatec). Relative Luciferase Units (RLU) were 
calculated. For the TOP/FOP assay we used the same procedure first described. 
The TK-TOP and TK-FOP optimal and mutated TCF luciferase-reporter 
constructs have been described previously [Staal, et al. 1999]. 
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4.RESULTS AND DISCUSSION  
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4.1.Phenotypic characterization of ML-Prune transgenic mice 
 
The transgenic mice ML-h-Prune were identified by 
genotyping (fig. 6 B). The expression of h-Prune were detected by a W.B. 
analysis first of the total skin, and after separately epidermis and dermis protein 
extracts using an anti-Prune antibody, able to detect both human and mouse 
proteins (fig 6 C). The result of WB shows an epidermal specific expression of 
h-Prune (fig 6 A). At birth transgenic pups were indistinguishable from their 
littermates, after 4-5 days transgenic mice (TG) were smaller than wild type 
littermates. ML-h-Prune transgenic mice showed a significantly thinner and 
more wrinkly skin compared to WT littermate (fig 6 D), which appeared red 
and flaky, showing an inflammatory like phenotype. Histological analysis of 
skin architecture on the dorsal skin, examined using haematoxylin and eosin-
stained sections, revealed that the epidermis of 5-old days ML-Prune 
transgenic pups appeared moderately hyperplastic, with a thinner dermis and 
higher granular and spinous layer than WT littermate (fig 6 E, panel I and II). 
Moreover immunohistochemical analysis of skin section with an anti-Prune, 
confirmed the overexpression of the protein seen for W.B. and showed an 
higher number of nucleated cells in the upper layer of ML-h-Prune epidermis 
respect to the WT (fig 6 E, panel III and IV ). We think this is due to a failure of 
cell differentiation program leading the immature cells to migrate to the outer 
layers of epidermis. The hypothesis about the alteration of  keratinocytes 
differentiation was strengthened by the immunostaining of skin section with an 
antibody direct against keratin 6 (K6): K6 regularly used as marker of 
proliferating cells in hair follicles and in skin pathologies [Weiss, et al. 1984] 
were found confined to the companion layer of the hair follicles in wild type 
controls while in transgenic mice it was found aberrantly expressed also in the 
epidermis (fig 6 F, panel V and VI) . Moreover keratin 14, marker for basal 
proliferating cells [Fuchs and Green 1980], analyzed by immunohistochemical 
staining showed a markedly aberrant immunoreactivity in superbasal layers of 
epidermis in transgenic mice (fig 6 F, panel VII and VIII). The overexpression 
of both cytokeratins in the ML-h-Prune transgenic skin was confirmed by WB 
analysis (fig 6 G and fig 6 H). The transgenic phenotype gradually disappeared 
and it was absent in adult animals, although the transgene was still expressed at 
moderated levels in adult mice. This phenomenon can be explain by the 
loricrin used promoter level of expression, highly functioning in the first weeks 
of mice inborn life and to the tight level of regulation occurring in epidermis 
that balances the overexpression of h-Prune, causing hyperproliferation, with 
concurring altered differentiation and apoptosis. Although this phenomenon is 
common in epidermal transgenic models [Waikel, et al. 1999] these results will 
be further investigated in the near future. The higher expression of the two 
keratins in the transgenic mouse skin was confirmed by WB (fig 6 C). 
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Fig 6.  ML-h-Prune transgenic mice characterization. (A)  The transgenic 
construct to obtain ML-h-Prune transgenic mice was generated by inserting the 
human h-Prune cDNA into the 6.5 Kb mouse modified loricrin expression vector. 
(B)  PCR analysis to detect the presence of transgene in mouse epidermis. (C)  
W.B. analysis of ML-h-Prune transgenic back-skin, showed that the protein was 
expressed in high levels specifically into epidermis. (D)  At 5 days of life 
transgenic mice were smaller than wild type littermates and showed a more 
wrinkly skin with an epidermis moderately hyperplastic, with a thinner dermis and 
higher granular and spinous layer (E-I and E-II). Immunohistochemical analysis of 
skin section with an anti-Prune, confirmed the overexpression of the protein seen 
for W.B. and showed an high number of nucleate cells in the upper layer of ML-h-
Prune epidermis respect to the WT (E-III and E-IV) (the dashed white line 
demarcates the separation between epidermis and dermis). (F)  
Immunohistochemical analysis with K6 and K14 antibody showed an higher and 
ectopic expression of both proteins in the ML-h-Prune transgenic mice (F-V and F-
VI;  F-VII and FVIII). The higher expression of K6 and K14 were confirmed by 
WB analysis (G and H)  
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4.2.Deregulation of skin barrier in ML-h-Prune transgenic mice  
 
Many mouse models carrying  alterations to the skin 
structure show an alteration also of the skin barrier [Koch, et al. 2000, Matsuki, 
et al. 1998]. The formation of a functional epidermal barrier occurs between 
E16.5 and E17.5 days and coincides with the formation of the stratum corneum 
[Hardman, et al. 1998]. To investigate if the skin barrier of ML-h-Prune 
transgenic mice was functionally, we performed an assay of skin permeability 
with Toluidine Blue staining. In these experiment the mouse analyzed 
belonged to the same progeny, so they were analyzed at the same 
developmental stage. In the figure 7 (left panel) we can observe that during 
embryonal stages (E16.5 and E17.5) of formation of skin barrier, no 
differences occur between ML-h-Prune transgenic mice and the WT littermate. 
Between the 5th and 6th day of life, two days after the maximum expression 
peak of  transgene, the ML-h-Prune model showed an higher absorption of the 
dye respect to the WT mouse, reflecting an higher permeability of the skin (fig 
7 right panel). These results lead us to think that h-Prune is able to interfere in 
the normal process of skin homeostasis. We therefore decided to investigate 
the molecular pathways underlying the phenotypical alteration observed in the 
h-Prune transgenic skin. 
 
 
 
Fig 7.  Skin barrier alteration of the ML-h-Prune transgenic mice.  No 
differences in skin barrier formation occur between ML-h-Prune transgenic mice and 
the WT littermate during embryonal stages (E16.5 and E17.5) (left panel). The ML-h-
Prune model showed an higher absorption of the dye between the 5th and 6th day of 
life, two days after the maximum expression peak of  transgene (right panel), thus 
indicating that the skin barrier at this stage is fully retaining the blue dye in the  ML-h-
Prune animals compared to wild-type animals.  
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4.3.Altered Wnt signaling in ML-h-Prune transgenic mice. 
 
 
From literature h-Prune and GSK-3β are known to 
interact. In vitro binding studies using recombinant proteins demonstrated that 
GSK-3β bound directly to h-Prune [Kobayashi, et al. 2006]. In addition, recent 
studies have found that GSK-3β is a central regulator of cell polarity and 
cytoskeleton dynamics [Nusse 2008]. In vivo, GSK-3β activity is inhibited by 
Wnt signaling, which in turn leads to β-catenin stabilization, which plays a 
critical and near universal role in epidermal stem cell (SC) activation and 
migration [Fuchs 2009, Nusse 2008]. 
    To investigate whether h-Prune was able to mediate a 
Wnt pathway activation, we examined epidermal active β-catenin performing 
blot analysis on both epidermis and dermis protein lysates, isolated from 5 days 
old ML-h-Prune mice. We observed a substantial increase in the active β-
catenin protein amount (fig 8 A left column), confirmed also by 
immunohistochemical that showed a markedly aberrant  nuclear staining of the 
protein (fig 8 B). This phenomenon was not observed in WT mice. These 
results prompted us to evaluate the activity of GSK-3β. The ability of GSK-3β 
to target substrates for degradation is attenuated through phosphorylation of the 
serine-9 residue [Doble and Woodgett 2003]. We demonstrated using specific 
antibodies specific for pSer9-GSK3β, that h-Prune overexpression enhances 
levels of the inactive form of GSK3β (pSer9-GSK3β) in the epidermis of these 
mouse model, observing that the proportion of the inactive GSK-3β protein 
was increased in ML-h-Prune mice (fig 8 A left column). Of note we observed 
also that GSK-3β protein level was found increased. It has been shown that 
cyclin D1 acts as direct target gene for β-catenin [Shtutman, et al. 1999], in 
agreement with this finding, western blot analysis showed that Cyclin D1 
protein was found indeed activated in the epidermis of ML-h-Prune mice 
[Zhang, et al. 2011]. 
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Fig 8.  Levels of canonical Wnt pathway related protein in epidermis 
and dermis of ML-h-Prune transgenic mice.  (A)  Western blot analysis of 
separated proteins extracts of epidermis and dermis of ML-h-Prune transgenic mouse 
compared to WT mouse. The transgenic mice showed higher inactive pSer9-GSK3β 
and consequent active-β-catenin levels in the epidermis. GSK3β levels showed no 
variation, while high levels of total β-catenin was found in the epidermis of transgenic 
animals. Also Cyclin D1 levels were increased in the epidermis of ML-h-Prune 
transgenic mice. (B) IHC analysis of ML-h-Prune transgenic skin showed high 
nuclear-β-catenin staining respect to WT mice. 
 
 
As we have previously shown,  h-Prune is a positive 
regulator of β-catenin signaling in our mouse model, for this reason we 
examined whether in in-vitro experiments h-Prune transfection drives β-catenin 
up-regulation in HACAT cells. To quantify β-catenin/LEF-mediated 
transcriptional activation, we transfected HACAT keratinocytes with the TOP-
flash reporter containing the LEF binding motifs and measured luciferase 
activities [Korinek, et al. 1997]. FOP-flash vector with mutated LEF sites were 
used as control. As shown in figure 9 A, the luciferase activity were 
significantly higher in h-Prune transfected keratinocytes compared with empty 
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vector transfected cells. The h-Prune protein comprises various domains; 
Kobayashi et al. in the 2006, showed that amino acid region 333 to 453 of h-
Prune was necessary and sufficient for the complex formation with GSK-3β. 
Here we examined, using the same methodology, which region was able to 
activate β-catenin/LEF-mediated transcriptional activation. Figure 9 B shows 
that h-Prune full length (amino acids 1-453) and h-Prune C-Terminus (amino 
acids 333-453) significantly activated transcription of reporter gene while h-
prune N-Terminus (amino acids 1-332) is not able to perform this at similar 
strenght. 
 
 
 
Fig 9.  Increased ignition of Tcf/Lef mediated transcription upon h-
Prune overexpression. (A) HACAT keratinocytes co-transfected with h-Prune 
expression vector and TOP-flash reporter showed increased levels of luciferase signal 
compared to empty vector/ TOP-flash reporter transfected cells. FOP-flash vector with 
mutated LEF sites was used as control. (B) Prune C-terminal region transfected cells 
showed  higher luciferase reporter signal compared to Prune full length transfected 
cells and to Prune N-terminal transfected cells, suggesting that the effective domain 
able to impairs the Wnt pathway is the amminoacidic sequence 333-453 (C-terminal 
region). 
 
 
4.4.H-Prune increases the transcription of Wnt target genes in the 
transgenic mouse epidermis 
 
Since h-Prune was able to increase β-Catenin 
transcriptional activity, we additionally explored whether or not h-Prune 
regulates the canonical WNT target genes transcription. If h-Prune 
overexpression enhance WNT signaling throughout pSer9-GSK3β stabilization 
and consequently by inhibition of β-catenin degradation we could gain 
additional indirect evidence through the enhancing of known early WNT target 
genes. For this purpose, we monitored the mRNA levels of  JAG1, Survivin 
(Birc5 gene transcript), cMyc,  and cyclin D1 by  real-time PCR using RNA 
from TG and WT epidermis. Within this assay, as expected, we found that 
JAG1, Survivin (Birc5 gene transcript), cMyc,  and cyclin D1, showed 
enhancement of ~ 2,6 - 1,6 - 1,7 and 1,4 fold respectively (fig 10). 
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Fig 10. Increased mRNA rates of Wnt target genes in the ML-h-Prune 
transgenic epidermis.  Real time PCR analysis detected higher mRNA levels of 
Wnt related genes in the transgenic epidermis: JAG1, Survivin, cMyc,  and cyclin D1 
was all upregulated in the ML-h-Prune transgenic mouse compared to WT mouse.  
 
 
For this purpose the next step of our work was to study 
the Notch pathway activation in ML-h-Prune transgenic epidermis. 
 
 
4.5.Negative regulation of Notch signaling in ML-h-Prune 
transgenic skin and phenotypic alterations. 
 
We have previously described several skin 
differentiation defects observed in our transgenic mouse model. Notch 
signaling has a key role in promoting keratinocyte differentiation exerting a 
growth-inhibitory function that can be attributed to CBF-1-dependent 
upregulation p21cip1 (Cdkn1a)  [Lefort and Dotto 2004, Lefort, et al. 2007]. In 
the embryonic mouse epidermis, Notch1 intracellular domain (NICD1) is 
ubiquitous in supra-basal keratinocytes selecting the spinous fate [Blanpain, et 
al. 2006, Lin and Kopan 2003, Pan, et al. 2004]; after birth, NICD1 is detected 
transiently in a small fraction of spinous cells [Lee, et al. 2007]. This pattern of 
Notch1 activation is consistent with its proposed role in suppressing 
proliferation and promoting differentiation through the modulation of several 
targets [Blanpain, et al. 2006, Mammucari, et al. 2005, Okuyama, et al. 2004, 
Rangarajan, et al. 2001]. Moreover in vitro studies have shown that following, 
ligand binding and proteolytic cleavage, intracellualar domain of Notch must 
be phosphorilated by GSK3-β to be active and capable  to migrate in the 
nucleus to enhance the transcription of target genes [Espinosa, et al. 2003, 
Foltz, et al. 2002]. 
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In searching for potential alterations of this pathway, in 
our transgenic mouse model (wich shows clear pro-differentiation defects), we 
investigated whether Notch signaling might be altered. 
Therefore, we tested whether Notch activity is altered 
upon h-Prune overexpression and whether, h-Prune impairs or enhances Notch 
signaling. 
To determine whether h-Prune was able to altered Notch 
signaling we first  measured by western blot experiments, the amount of 
cleaved intracellular domain of Notch (NICD, activated form of Notch) that 
was present. We found that, in epidermis of ML-h-Prune TG mice compared 
with WT littermate, the amount of NICD was markedly increased (fig 12). 
Next we explored the protein expression of Notch target gene such as p21, 
hes1 and hey1 [Lefort and Dotto 2004]. By contrast western blot analysis from 
these mice revealed no variation in protein amount. The lack of an overt 
variation, following NICD activation, of these targets suggest that h-
Prune/GSK3-β interaction also influences Notch signaling activation in the 
skin. Of note filaggrin, that is required for keratin bundle formation and correct 
biogenesis of the stratum corneum, showed a decreased level of staining in 
ML-h-Prune mice, confirming an impaired differentiation program and raising 
the possibility that Notch signaling may be altered in these mice. 
Notch signaling induces suprabasal-specific genes such 
as Keratin1 and Keratin10 and represses basal genes such as Keratin15 (K15) 
and the β1 and α6 integrins [Moriyama, et al. 2008]. Immunohistochemical 
analysis of keratin 15 in ML-Prune TG skin showed a normal distribution of 
K15 both in WT and ML-h-Prune mice. However in ML-Prune mice were 
observed a double layer of K15 positive cells in the basal compartment of 
epidermis compared to WT littermate (fig 11). No substantial histological 
alterations were found in the bulge region, dermal papilla and infundibulum. 
 
 
 
Fig 11. K15 staining of ML-H-Prune transgenic skin showed a bilayer of K15 
positive cells (arrowheads) respect to the single layer of K15 positive basal cells in the 
WT mice.  
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Western blot analysis on protein skin extracts confirmed 
that K15 was expressed at higher levels in the ML-h-prune TG mice and that 
their up-regulation is correlated to h-Prune levels of expression (fig 12). 
 
 
 
 
Fig 12. Increased levels of Notch1 receptor clivation in the ML-h-Prune 
transgenic skin. WB analysis showed an high clivated an internalized Notch1 
membrane receptor (NICD1). This cleavage however did not lead to an increase of 
Nocht1 transcriptional target as Hes1 and Hey 1 and related protein as p21 in ML-h-
Prune transgenic skin. Instead the inversely correlated with Notch pathway activation 
cytokeratin 15 (K15) showed a clear increase of its expression in the transgenic 
epidermis.  
 
 
 
4.6.The higher rate of Notch receptor cleavage is not reflected in the 
activation of its transcriptional targets in the ML h-Prune skin 
 
To gain insight into the role of Notch signaling, we further investigated, 
why we did not observed any protein variation although upstream pathway was 
found activated. To address this finding we asked whether the impairment 
might be due to a transcriptional level or a translational level. By qRT-PCR we 
analyzed the mRNA levels of the canonical Notch targets and genes related to 
its activation. The best characterized targets of Notch/CBF-1/MamL mediated 
activation are members of the HES and HERP families of bHLH 
transcriptional repressors [Iso, et al. 2003]. Furthermore the cyclin/CDK 
     43 
inhibitors p21WAF1/Cip1 and p27 have emerged as important targets under 
positive Notch1 control in mouse keratinocytes, both in culture and in the 
intact epidermis in vivo, which mediate the growth inhibitory effects of Notch1 
activation [Nicolas, et al. 2003, Philipp, et al. 1999, Rangarajan, et al. 2001]. 
mRNA expression of Notch canonical targets  Hes 1, Hes 5, p21, and p27  
were found invalidated between the two mouse models (fig 13).   
 
 
Fig 13. Detection of trascriptional rate of Notch related genes.  The 
epidermal mRNA amount of direct targets of canonical Notch signaling like Hes 1, 
Hes 5 as well as Notch  related genes like p21, p27 and K15 was not significantly 
upregulated in ML-h-Prune transgenic epidermis respect to control. 
 
 
 
 
To obtain an umpteenth confirm of transcriptional inhibition exerted by 
h-Prune on Notch signaling we carried out additional experiment using Notch 
luciferase reporter vector containing multiple CBF1 binding sites (CBF-luc). 
For this purpose Hek 293 cells were co-transfected with CBF-luc and h-Prune 
expression vector (pCS4-3xflag-H-Prune) or CBF-luc and empty vector as 
control. 24 hours later, transfected cells were plated and treated or not for 
additional 12 h with a potent GSK3β inhibitor SB216763. Then the cells were 
lysed and the luciferase was detected. As is shown in figure 14, h-Prune 
transfection led to an impairment of Notch transcriptional activity, revealed by 
a decrease in the luciferase amount. Moreover in the SB216763 treated-h-
Prune transfected cells we observed  further inhibition of the luciferase signal 
thus indicating that SB216763 and h-Prune cooperatively act on Notch 
transcriptional impairment. This data strengthens the evidence that Notch 
signaling impairment occurs at transcriptional level, following GSK3β 
inactivation carried out by h-Prune.  
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Fig 14. Effect of H-Prune overexpression and GSK3β  inactivation on 
the downstream Notch signaling. Hek 293 cells transfected with a luciferase 
reporter vector containing multiple CBF1 binding sites (CBF-luc) and with an 
expression vector for h-Prune protein (pCS4-3xflag-H-Prune) treated and untreated 
with GSK3β inhibitor SB216763. In the untreated cells Prune transfection carried a 
reduction of the CBF mediated transcription that was comparable to the empty vector 
transfected - SB treated cells. A further reduction of the luciferase signal was observed 
in the h-Prune transfected - SB treated cells. 
 
 
4.7.Phenotypical alterations in ML-h-Prune transgenic skin 
related to downregulated Notch pathway. 
 
The results described above showed an interesting in- 
vitro and in-vivo role for h-Prune in the regulation of Notch signaling, thus 
indicating that h-Prune can function as suppressor of Notch signaling in  the 
skin. To test this hypothesis, we observed the fenotipical alteration related to 
nocth signaling deregulation. In the stratum corneum the keratin filaments 
align into macrofibres, under the influence of Filaggrin, the protein component 
of the keratohyalin granule, responsible for keratin filament aggregation: this 
fiber with the lipid secreted by keratinocytes are the main component of the 
skin barrier. Loss of canonical Notch signaling causes severe epidermal barrier 
and differentiation defects highlighted by reduced spinous, granular, and 
cornified layer cells [Blanpain, et al. 2006]. Hematoxylin and eosin-stained 
sections, revealed that the epidermis of 5-old days ML-Prune transgenic pups 
shows disrupted epidermal macrofibres with less compact clusters of 
keratohyalin granule (fig 15 A). Moreover immunohistochemical analysis 
against Filaggrine, to monitoring the distribution of this protein in the 
epidermal layer, showed a lesser immunoreactivity in the transgenic mice 
compared with WT control with the signal  not located in the stratum corneum 
but rather spread in the thickness of suprabasal layers (fig 15 B). This data 
confirm that the basal compartment of transgenic mice is less exposed to Notch 
signaling which leads to hyperproliferation of the superbasal layer, in 
agreement with mouse models for Notch KO founded in literature [Lefort, et 
al. 2007, Moriyama, et al. 2008, Nicolas, et al. 2003]. 
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Fig 15. Phenotypical alteration of ML-H-Prune transgenic epidermis 
related to Notch pathway decreasing activation. (A) H/E staining of 
transgenic epidermis revealed disrupted epidermal macrofibres with less compact 
clusters of keratohyalin granule into transgenic epidermis. (B)  IHC against filaggrin 
showed less marked staining in the transgenic mice compared with WT control. The 
signal  was not located in the stratum corneum but rather spread in the thickness of 
suprabasal layers. 
 
 
 
4.8.Following in vivo the Wnt activation.  The ML-h-
Prune/pVegfr2-luc transgenic mice. 
 
The aim here was to confirm the above-described 
evidence concerning the in vivo effect of h-Prune on WNT signaling 
activation. Since Zhang and colleagues in the 2001 provided clear evidences 
that VEGF was strongly upregulated by the Wnt signaling pathway [Zhang, et 
al. 2001], here using the transgenic mouse pVegfr2-luc, in which the luciferase 
reporter is under control  of murine Vegfr2 promoter, allowing to follow the 
WNT activation in vivo by enhancement of bioluminescence [Zhang, et al. 
2004]. For this reason we created a double transgenic mouse model crossing 
our ML-h-Prune mouse (CD1) model with Vegfr2-Luc transgenic mouse 
(FVB/N) (fig 16 A). This line was backcrossed to FVB/N for 10 generations, 
generating albino ML-h-Prune/pVegfr2-luc transgenic animals (FVB/N). We 
validate h-Prune expression by both  PCR (not shown) and WB within mouse 
epidermis.  
In the epidermis of ML-h-Prune/Vegfr2-luc we found 
similar levels of expression of the human protein respect to the previous 
described ML-h-Prune transgenic mice (fig 16 B). 
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Fig 16. ML-h-Prune/pVegfr2-luc double transgenic mice.  (A) Schematic 
representation of the cross pVegfr2-Luc and ML-h-Prune transgenic mice to obtain a 
double transgenic mice carrying both genes. (B)  WB against Prune to validate the 
expression levels of the transgenic protein in the ML-h-Prune/pVegfr2-luc  double 
transgenic mouse. 
 
 
Moreover Western Blot analysis to better characterize 
the double transgenic mice ML-hPrune/pVegfr2-luc showed the same levels of 
ser9-p-GSK3β, total GSK3β, active β-catenin, total β-catenin  and Cyclin D1 
were detected in the ML-hPrune/pVegfr2-luc transgenic epidermis, as 
consequence of Wnt pathway activation  (fig 17 A).  On the other hand the 
protein amount of Notch pathways target gene shared the same trends in the 
epidermis of previous analyzed ML-h-Prune transgenic mice (fig 17 B). Finally 
since VEGFa is a downstream Wnt gene target, we expected an enhancement 
of bioluminescence in vivo in this ML-h-Prune/pVegfr2-luc.  In figure 17 
panel C we observed a substantial increase photons emission in ML-h-
Prune/pVegfr2-luc (mice #6 - #10) with respect to the p Vegfr2-luc (mice #1 - 
#5) transgenic animal. The difference of bioluminescence was higher between 
the 4th and 5th day of animal life, in according with the peak of h-Prune protein 
expression. After the 5th day of life, the differences in bioluminescence 
emission were gradually disappearing, according to what is reported in 
literature about the modified loricrin promoter ML [Waikel, et al. 1999]. Taken 
together, these results have revealed an important regulatory mechanism, 
exerted by h-Prune, within WNT pathway, inactivation of GSK3β proteins, 
that in turns could be exploited to an enhanced levels of Wnt pathway 
response. 
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Fig 17 . Characterization of the ML-h-Prune/pVegfr2-luc transgenic 
mice. WB analysis for the Wnt pathway (A)  and Notch pathway (B)  related proteins 
showed the same protein levels in the epidermis of the previous ML-h-Prune single 
transgenic mice. (C)  Photon emission in 5-days old ML-h-Prune/pVegfr2-luc 
respect to pVEGFR2-luc transgenic mice. The higher bioluminescence was a 
proof of the major activation of VEGFR2 promoter. 
 
 
4.9.H-Prune and human skin inflammatory diseases.  
 
The results obtained above, showed that h-Prune is able 
to upregulate the Wnt canonical pathway. This leads to a decrease of Notch 
signaling activation revealed by decrease of its downstream Notch targets in 
the epidermis of ML-h-Prune transgenic mice. An increase in “Wnt/β–catenin” 
signaling is likely to be biologically significant, and has been associated with a 
wide number of skin malignancies including inflammation, cancer and 
psoriasis [Chan, et al. 1999, Moon, et al. 2004]. In particular in psoriatic skin 
was observed a strong nuclear localization of β-catenin in suprabasal layers 
[Hampton, et al. 2007] and also an increased expression of VEGF [Hardas, et 
al. 1996], both proteins related to the Wnt canonical pathways and were found 
upregulate in the ML-h-Prune transgenic mice. Moreover in the skin, Notch1 
has a role in promoting keratinocyte differentiation and defects in the Notch 
pathway are thought to be involved in the pathogenesis of psoriasis. Notch 
signaling molecules are up-regulated in the basal and differentiating layers of 
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adult human epidermis, whereas they are under-expressed in disorganised 
proliferating epidermis [Rangarajan, et al. 2001, Thelu, et al. 2002].  
Besides H-PRUNE is located in the 1q21.3 
chromosomal region, 1Mb upstream the epidermal differentiation complex 
(EDC), a region which shows a remarkable density of genes that fulfil 
important functions in terminal differentiation of the human epidermis 
[Mischke, et al. 1996]. Linkage studies have shown in this region two 
susceptibility loci for skin inflammation disorders such as psoriasis [Capon, et 
al. 1999, Hardas, et al. 1996] and atopic dermatitis [Cookson, et al. 2001] for 
which  no genes have been yet identified.  
Taken together all these evidences, here we 
investigate the possible role of h-Prune may take part in human skin diseases 
like psoriasis which is known to occurs by a multi-genetic factors.  
 
 
4.10.In human keratinocytes h-Prune overexpression reproduces 
the Wnt signaling activation. 
In order to verify whether h-Prune overexpression was 
able to reproduce the same effects observed in our mouse model, also in human 
context, we used a HACAT cell line as a model for in-vitro studies. H-Prune 
overexpression in HACAT keratinocyte cell line leads to an increase in the 
amount of the inactive ser9-P-GSK3β with the consequent increase of active β-
catenin, while total GSK-3β protein quota was unvaried (fig 18 A), with a 
weak enhancement of downstream target cyclin D1 (fig 18 B) . This data 
confirm the Prune-mediated unbalance of Wnt pathway also in the human cell 
model.  
 
 
Fig 18. Alterated Wnt and Notch downstream related protein upon H-
Prune ovexpression in HACAT cell  l ine.  HACAT cells were transfected 
with pCS43x-Flag-h-Prune (Prune) and pCS43x-Flag-Empty Vector (E.V.). 
(A)  In response to h-Prune overexpression high levels of active β-catenin, 
ser9-P-GSK3β and GSK3β quota were shown. No differences could be 
appreciated for total β-catenin. (B)  A little decrease of Hes 1 protein occurred 
upon Prune overexpression, while no difference could be appreciated for 
Cyclin D1. 
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4.11.Evidence of increased levels of h-Prune in human psoriatic 
samples and its correlation with β-catenin nuclearization. 
 
In order to verify the role of Prune in a context of human 
overgrowth skin disease, we decided to evaluate h-Prune protein levels by 
immunohistochemical analysis on a collection of human psoriatic samples and 
on an equal number of healthy skin samples, using an antibody against Prune 
(the same used for the mouse skin analysis). In all normal skin samples 
analyzed h-Prune showed a perinuclear and cytoplasmatic staining, and the 
signal is confined only in the basal layer of epidermis (fig 19 I and III). 
Interestingly almost all samples of psoriatic skin analyzed revealed an altered 
expression of h-Prune, showing a marked increase of immunoreactivity against 
the protein in all four layer of epidermis (fig 19 II and IV ).  
 
 
 
Fig 19. Overexpression of h-Prune in human psoriatic samples.  
Immunohistochemistry analysis of normal human skin and psoriasis sections with an 
antibody against Prune, showed that in normal skin samples h-Prune had a perinuclear 
and cytoplasmatic staining, and the signal was confined only in the basal layer of 
epidermis. h-Prune amount is strongly increased in psoriatic samples with a 
cytoplasmatic distribution. Nuclear staining for h-Prune was observed only in 
some cases and it was restricted to the more external layer (panel IV  
arrowheads). 
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The higher amount of Prune protein found in human 
psoriatic lesions compared to the normal samples provided a potential evidence 
for h-Prune involvement in this pathological disorder. Previous obtained data 
on our h-Prune mouse model showed that the high protein expression levels led 
to an increase in activation of Wnt pathway. In order to verify if the same event 
could occur in human psoriatic sample characterized by altered expression 
levels of Prune, we performed immunohistochemical analysis on serial slices 
of psoriatic skin samples with both an anti-Prune antibody and an antibody that 
specifically recognize the active β-catenin form. The figure 20 showed that 
high expression levels of h-Prune (fig 20 I and II), directly correlates with an 
increased of β-catenin nuclearization (fig 20 III and IV ). A higher nuclear 
localization in the psoriatic lesion was already observed by Hampton et 
colleagues in 2007 [Hampton, et al. 2007]. Taken together our findings suggest 
a direct correlation between h-Prune overexpression and β-Catenin 
nuclearization in psoriatic samples, thus identifying h-Prune as a protein 
upregulated in psoriasis. At this time these evidences could be the base for 
future studies to identify a potential direct correlation between h-Prune and  
pathogenesis of psoriasis. 
 
 
 
Fig 20.  H-Prune and active β-catenin staining in serial psoriatic 
sections.  Psoriatic skin sections screened for Prune and active β-catenin, showed a 
merge in the areas of expression of both proteins. β-catenin showed an higher 
nuclearization in the same areas of psoriatic epidermis that had higher expression 
levels of Prune. Arrowheads indicate the β-catenin positive nuclei.  
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4.12.Discussion 
 
H-Prune protein is known to date to stimulate cellular 
motility and metastasis process in a breast cancer model [D'Angelo, et al. 
2004]. The role of h-Prune in the increased cell motility can be explained in 
part to h-Prune interaction with GSK-3β with which cooperatively works to 
regulate the disassembly of focal adhesions and promote cell migration 
[Kobayashi, et al. 2006].  
In the present study we use a transgenic mouse model to 
investigate the role of h-Prune in the epidermis and its possible involvement in 
inflammatory/hyper-proliferative skin disorders highlighting  the effects of h-
Prune overexpression in  unbalancing the Wnt and Notch signaling, two of the 
main pathways that regulate skin homeostasis [Artavanis-Tsakonas, et al. 1999, 
Gat, et al. 1998, Ito, et al. 2007, Lefort and Dotto 2004, Moriyama, et al. 2008, 
Zhang, et al. 2011]. 
We show Prune expression in both human and mouse 
skin to have a distinct pattern of expression in proliferating cells, thus 
suggesting its role in normal proliferation [Forus, et al. 2001]. High levels of h-
Prune expression in the mice epidermis are correlated with a wrinkly skin with 
an epidermis moderately hyperplastic, with a thinner dermis and higher 
granular and spinous layer (fig 6 E). The failure of cell differentiation program 
is more evident in the upper layer of ML-h-Prune epidermis that shows an 
higher number of nucleated cells in this compartment respect to the WT mice 
which can be explained by the hyper-proliferation and delayed onset of 
differentiation in the suprabasal layers (fig 6 E, panel III and IV ). Moreover in 
the ML-h-Prune transgenic mice skin can be noted disrupted epidermal 
microfibres with less compact clusters of keratohyalin granule (fig 15 A) and 
filaggrine not located in the stratum corneum but rather spread in the thickness 
of suprabasal layers (fig 15 B).  
All these epidermal alterations lead to defects in the skin 
barrier structure in the 6 days old transgenic animals (fig 7), that occurs two 
days after the maximum peak of expression of Loricrin promoter driven h-
Prune transgene. This phenomenon has already been observed in other 
Loricrin-transgenic models highly expressed in the window of time between 
the 4th and 6th day of mice life  [Waikel, et al. 1999].  
Since GSK-3β is a h-Prune protein interactor, then the 
knowledge of GSK-3β as negative regulator of Wnt/β-catenin canonical 
signaling, we hypothesized at this time that the observed phenotypic alterations 
in the ML-Prune transgenic mice could be accounted to an inhibition of the 
negative regulation of GSK-3β, thus resulting on an enhancement of the 
downstream Wnt/β-catenin signaling. Wnt deregulation infact leads to an 
inbalance of proliferation and differentiation, often resulting in cancers [Reya, 
et al. 2001]. β-catenin controls lineage selection of epidermal stem cells: high 
levels of β-catenin activation favours hair follicle differentiation, whereas 
inhibition of activation favours interfollicular epidermal differentiation [Fuchs, 
et al. 2004, Niemann and Watt 2002].  
Hence we provide by WB and real time analysis the 
proof that h-Prune overexpression leds to Wnt pathway activation and 
inhibition of β-catenin degradation. This model should provide a basis for 
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future studies. Within the context in which β-catenin is activated, we observed 
an increased of basal cells proliferation in our transgenic mouse evidenced by 
an overexpression of keratin 14 (fig 6 F and H), which labels proliferative cells 
in the basal layer of the epidermis.  Moreover we identify the h-Prune region 
able to turn on the Wnt pathway: C-Terminal portion (amminoacidic region 
333-453), that is reported in literature to physically interact with GSK-3β 
[Kobayashi, et al. 2006], is able alone to upregulate the β-catenin-dependent 
transcriptional activity (TOP/FOP assay fig 9 B). 
Interestingly, in the h-Prune transgenic skin we found 
elevated levels not only of inactive Ser-9-P-GSK3β, but also of GSK-3β 
protein quota. In literature is reported that when the Wnt pathway is active, 
Ser9-P-GSK3β  is sequestered from the cytosol into multivesicular bodies, so 
that this enzyme becomes separated from its many cytosolic substrates, but in 
the same time is protected from protease degradation [Taelman, et al. 2010]. 
Preliminary data suggest us that Prune is able to increase the levels of Ser9-P-
GSK3β that enter into multivescicular bodies to be protected from 
degradation. However further analysis are  required to elucidate this issue. Our 
results are in keeping with these observations and provide the first direct 
evidence that h-Prune is essential for canonical Wnt signaling, but additional 
studies are required to clarify the role of this protein within this pathway. 
Among the target genes of the Wnt pathway that we found upregulated in the 
ML-h-Prune transgenic skin, there is the Notch ligand JAG1, which induces 
Notch1 signaling activation.  
Notch1 is essential for coordination of keratinocyte 
growth and differentiation in vivo [Rangarajan, et al. 2001]. Notch signaling is 
required for commitment of basal keratinocytes to spinous cell differentiation 
at early stages of epidermal development [Blanpain, et al. 2006]. By contrast, 
postnatal ablation of Notch1 causes hyperproliferation of basal keratinocytes, 
suggesting that signaling from Notch1 is required for cell cycle withdrawal of 
the basal keratinocytes to promote terminal differentiation in the postnatal 
epidermis [Nicolas, et al. 2003, Rangarajan, et al. 2001].  
Despite we found an high cleavage of Notch membrane 
receptor, the phenotype of the ML-h-Prune transgenic skin was similar to 
mouse model of Notch epidermal Knock Out present in literature showing an 
higher spinous and granular layers, high expression of cytokeratin 15 and 
disrupted kerathoyalin fibers [Moriyama, et al. 2008].  WB and Real time 
analyses revealed that the cleavage of Notch1 receptor in membrane and his 
internalization not carried  to the pathway activation in transgenic epidermis 
(fig 12 and 13). We linked this observation with the increased GSK-3β 
inactivation  found in the ML-h-Prune transgenic epidermis. GSK-3β is able to 
bind and phosphorylate NICD1 in vitro and attenuation of GSK-3β activity 
reduced the phosphorylation of NICD1 in vivo [Foltz and Nye 2001]. We 
verify this observation by a luciferase assay in HACAT cells: untreated cells 
transfected with h-Prune carried a reduction of the CBF mediated transcription 
that was comparable to the empty vector transfected cells treated with the 
potent GSK-3β inhibitor SB216763 (fig 14). 
Moreover in this work for the first time we generate a 
useful tool to follow the Wnt pathway activation in vivo. Since VEGF is 
strongly upregulated by the Wnt signaling pathway [Zhang, et al. 2001] we 
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exploited this information to create the double transgenic mice pVegfr2-
luc/ML-h-Prune that allow us to monitoring the downstream Wnt pathway 
effectors in vivo (fig 17 C). 
Hence taken together, these results have revealed a 
regulatory mechanism, exert by h-Prune, within WNT pathway, inactivation of 
GSK-3β proteins, that could be exploited in an enhancement of Wnt pathway 
and at same time in a downregulation of the Notch 1 pathway. The sum of both 
events led to a failure to basal keratinocytes differentiation program 
characterized by hyperproliferative and hyperplastic epidermis. Summarizing 
the results obtained so far, we hypothesized the following model to explain the 
action of Prune in the skin.   
 
 
 
Fig 21.  Proposed model of prune overexpression into the skin.  Normally 
H-Prune is confined into basal layer of epidermis. As results of its overexpression 
occurs an increasing of GSK-3β phosphorilation rate which leads to inactivation of the 
latter. Phosphorylated GSK-3β is no longer able to phosphorylate β-catenin which 
escape from degradation, accumulates in the cells and enter into the nucleus to 
activate the Wnt target genes. Among the genes upregulated by Wnt pathway 
activation, there are also the Vegf and the Notch ligand Jagged1 (JAG1), that leads to 
an increasing in the amount of membrane Notch 1 clivation and internalization in the 
neighbour cells. At same time phosphorylated GSK-3β is no longer able to 
phosphorylates the intracellular clivated Notch1, then leading to the failure of 
downstream Notch signaling activation 
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These results lead us to investigate a possible 
involvement of h-Prune in a context of human overgrowth skin disease like 
Psoriasis. 
The novelty of our work is the analysis of h-Prune 
protein levels in human psoriatic samples. For the first time we show elevated 
levels of Prune in this type of disease compared to the lower and specifically 
basal expression of the protein in the normal skin samples (fig 19). In such 
analysis we demonstrate furthermore a merge of h-Prune and nuclear β-catenin 
staining in serial psoriatic skin section (fig 20). We suppose that in the skin h-
Prune works like a switch: in psoriatic samples high h-Prune levels correspond 
to increased Wnt signaling which led to the consequent Notch pathway 
inactivation. Conversely in the normal skin low levels of Prune do not turn on 
the Wnt pathway and the Notch downstream targets are normally active. Below 
we proposed a schematic representation of the balance between Wnt and Notch 
mediated by Prune in psoriatic skin. At this time these evidence will be the 
basis for additional studies in order to definitively infeer a direct correlation of 
h-Prune into psoriatic disorders. 
 
 
 
 
 
Fig 22. Equilibrium between Wnt and Notch pathway mediated by 
Prune. In the Psoriasis, the high expression of Prune protein leads to an increase in 
the Wnt pathway and consequent Notch pathway inactivation. Conversely in the 
normal skin low levels of Prune expression do not interfere in the normal 
differentiation program mediated by Notch. 
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5.CONCLUSIONS 
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The purpose of our study was to understand the role of h-
Prune in epidermal proliferation and keratinocyte-differentiation using a  
transgenic mouse model overexpressing the human protein into epidermis. We 
wanted first to characterized  the phenotype of transgenic mice and to elucidate 
the molecular mechanism occurring in the skin of these animals. Moreover, we 
wanted to frame h-Prune function in the most frequent hyperproliferative 
disease of the skin, the psoriasis. In this regard we used the ML-h-Prune 
transgenic mice to conduct our studies. 
In summary, our data demonstrate a functional role for h-
Prune in regulating normal skin homeostasis, and implicate its altered 
expression in hyperproliferative skin diseases. Moreover we provide clear 
evidence of a regulatory mechanism in the balance of activation of the Wnt and 
Notch pathway mediated by Prune in the skin of transgenic animals. Moreover 
the double transgenic mouse pVegfr2-luc/ML-h-Prune that we have generated, 
was not only  an useful tool to follow the trend of Wnt pathway in vivo but this 
animal should be a good candidate to test drugs able to impairs the h-Prune 
influence on the Wnt pathway. 
Finally, we assert an involvement of h-Prune in the pathogenesis of psoriasis, a 
disease for which a multigenes function is postulated. Future studies are 
required to clarify if Prune protein overexpression would be epistatic to the 
pathogenesis of psoriasis and/or if his levels are found increased following 
inflammation status of the damage tissue. If the first hypothesis occurs, h-
Prune could represent a molecular target for therapy of hyperproliferative/ 
inflammatory skin disorders including psoriasis. 
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